STOCK TITAN

[10-Q] O-I Glass, Inc. Quarterly Earnings Report

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
10-Q
Rhea-AI Filing Summary

Celularity Inc. filed an 8-K reporting a private placement executed on 14 Jul 2025 with one institutional investor. The company will sell 1,230,769 Class A shares plus matching two-year warrants at a combined price of $1.625 per unit, generating $2.0 million in gross proceeds. Warrants are immediately exercisable at $1.50 and, if fully exercised, could add ≈$1.85 million more.

Securities are being issued under a Section 4(a)(2)/Rule 506(b) exemption and therefore are unregistered. Net proceeds are earmarked for working capital and general corporate purposes. The Purchase Agreement and Warrant include customary reps, warranties and closing conditions; full forms are attached as Exhibits 10.1 & 10.2.

The equity issuance implies an estimated ≈3-4 % dilution to the current share base, with incremental dilution possible upon warrant exercise. While the raise bolsters short-term liquidity, the relatively small size highlights Celularity’s ongoing reliance on external financing to advance its placental-derived cell therapy programs.

Celularity Inc. ha depositato un 8-K segnalando un collocamento privato effettuato il 14 luglio 2025 con un unico investitore istituzionale. La società venderà 1.230.769 azioni di Classe A più warrant abbinati con durata biennale a un prezzo combinato di 1,625 $ per unità, generando 2,0 milioni di dollari di proventi lordi. I warrant sono esercitabili immediatamente a 1,50 $ e, se esercitati completamente, potrebbero aggiungere circa 1,85 milioni di dollari in più.

I titoli vengono emessi ai sensi dell’esenzione Sezione 4(a)(2)/Regola 506(b) e pertanto sono non registrati. I proventi netti sono destinati a capitale circolante e scopi aziendali generali. Il Contratto di Acquisto e il Warrant includono dichiarazioni, garanzie e condizioni di chiusura consuete; i moduli completi sono allegati come Allegati 10.1 e 10.2.

L’emissione di azioni implica una diluizione stimata di circa 3-4% sulla base azionaria attuale, con ulteriore diluizione possibile in caso di esercizio dei warrant. Sebbene l’aumento rafforzi la liquidità a breve termine, la dimensione relativamente contenuta evidenzia la continua dipendenza di Celularity dal finanziamento esterno per portare avanti i suoi programmi di terapia cellulare derivata dalla placenta.

Celularity Inc. presentó un 8-K informando sobre una colocación privada realizada el 14 de julio de 2025 con un único inversor institucional. La compañía venderá 1.230.769 acciones Clase A más warrants a dos años a un precio combinado de $1.625 por unidad, generando $2.0 millones en ingresos brutos. Los warrants son ejercitables inmediatamente a $1.50 y, si se ejercen completamente, podrían añadir aproximadamente $1.85 millones adicionales.

Los valores se emiten bajo una exención de la Sección 4(a)(2)/Regla 506(b) y, por lo tanto, están no registrados. Los ingresos netos están destinados a capital de trabajo y fines corporativos generales. El Acuerdo de Compra y el Warrant incluyen representaciones, garantías y condiciones de cierre habituales; los formularios completos están adjuntos como Anexos 10.1 y 10.2.

La emisión de acciones implica una dilución estimada de aproximadamente 3-4% sobre la base accionaria actual, con una posible dilución adicional si se ejercen los warrants. Aunque la recaudación fortalece la liquidez a corto plazo, el tamaño relativamente pequeño destaca la continua dependencia de Celularity del financiamiento externo para avanzar en sus programas de terapia celular derivada de la placenta.

Celularity Inc.는 2025년 7월 14일 단일 기관 투자자와 체결한 사모 배정에 대해 8-K 보고서를 제출했습니다. 회사는 1,230,769주 클래스 A 주식과 2년 만기 워런트를 단위당 1.625달러의 결합 가격으로 판매하여 총 200만 달러의 총 수익을 창출할 예정입니다. 워런트는 즉시 행사 가능하며 행사 가격은 1.50달러이고, 전액 행사 시 약 185만 달러가 추가로 발생할 수 있습니다.

증권은 섹션 4(a)(2)/규칙 506(b) 면제에 따라 발행되며, 따라서 등록되지 않은 증권입니다. 순수익은 운영 자금 및 일반 기업 목적에 사용될 예정입니다. 매매 계약서와 워런트에는 일반적인 진술, 보증 및 종결 조건이 포함되어 있으며, 전체 양식은 부록 10.1 및 10.2에 첨부되어 있습니다.

이번 주식 발행은 현재 주식 기반 대비 약 3-4%의 희석 효과를 의미하며, 워런트 행사 시 추가 희석 가능성이 있습니다. 이번 자금 조달은 단기 유동성을 강화하지만, 비교적 소규모라는 점은 Celularity가 태반 유래 세포 치료 프로그램을 진행하기 위해 외부 자금 조달에 계속 의존하고 있음을 보여줍니다.

Celularity Inc. a déposé un 8-K rapportant un placement privé réalisé le 14 juillet 2025 avec un investisseur institutionnel unique. La société vendra 1 230 769 actions de Classe A ainsi que des bons de souscription assortis d’une durée de deux ans à un prix combiné de 1,625 $ par unité, générant 2,0 millions de dollars de produits bruts. Les bons de souscription sont immédiatement exerçables à 1,50 $ et, s’ils sont entièrement exercés, pourraient apporter environ 1,85 million de dollars supplémentaires.

Les titres sont émis dans le cadre d’une exemption Section 4(a)(2)/Règle 506(b) et sont donc non enregistrés. Les produits nets sont destinés au fonds de roulement et aux besoins généraux de l’entreprise. Le contrat d’achat et le bon de souscription comprennent des déclarations, garanties et conditions de clôture habituelles ; les formulaires complets sont joints en annexes 10.1 et 10.2.

L’émission d’actions implique une dilution estimée d’environ 3-4 % de la base actuelle d’actions, avec une dilution supplémentaire possible en cas d’exercice des bons de souscription. Bien que cette levée de fonds renforce la liquidité à court terme, sa taille relativement modeste souligne la dépendance continue de Celularity au financement externe pour faire avancer ses programmes de thérapie cellulaire dérivée du placenta.

Celularity Inc. hat am 14. Juli 2025 eine private Platzierung mit einem institutionellen Investor durchgeführt und dies in einem 8-K-Bericht gemeldet. Das Unternehmen verkauft 1.230.769 Class A Aktien sowie dazu passende zweijährige Warrants zu einem kombinierten Preis von 1,625 $ pro Einheit, was einen Bruttoerlös von 2,0 Millionen Dollar generiert. Die Warrants sind sofort ausübbar zu 1,50 $ und könnten bei vollständiger Ausübung etwa 1,85 Millionen Dollar zusätzlich einbringen.

Die Wertpapiere werden unter einer Section 4(a)(2)/Regel 506(b) Befreiung ausgegeben und sind daher nicht registriert. Die Nettoerlöse sind für Umlaufvermögen und allgemeine Unternehmenszwecke vorgesehen. Der Kaufvertrag und die Warrants enthalten übliche Zusicherungen, Gewährleistungen und Abschlussbedingungen; vollständige Formulare sind als Anlagen 10.1 und 10.2 beigefügt.

Die Aktienausgabe bedeutet eine geschätzte Verwässerung von etwa 3-4 % der aktuellen Aktienbasis, mit zusätzlicher Verwässerung bei Ausübung der Warrants. Obwohl die Kapitalerhöhung die kurzfristige Liquidität stärkt, verdeutlicht die relativ geringe Größe die anhaltende Abhängigkeit von Celularity von externer Finanzierung zur Weiterentwicklung seiner plazentabasierten Zelltherapieprogramme.

Positive
  • $2 million gross proceeds provide immediate liquidity for working capital.
  • Warrants priced above the unit price ($1.50 vs. $1.625), limiting near-term downward pressure.
Negative
  • Issuance of 1.23 M shares and equal warrants causes dilution of roughly 3-4 %, with more if warrants exercised.
  • Small raise relative to probable cash burn indicates continued financing risk.

Insights

TL;DR: $2 M cash in at modest discount aids liquidity but adds dilution; impact neutral-slight positive.

The $2 M injection lengthens Celularity’s cash runway by only a few quarters yet comes at an acceptable 8-9 % discount to the warrant strike. Investors should note the two-year warrants could double share issuance at a marginal premium, capping upside. Because the raise is small relative to cash burn, it postpones but does not remove further capital-raising risk. Overall balance-sheet effect is beneficial but not transformative.

TL;DR: Transaction signals continuing funding need; limited but helpful liquidity for pipeline progress.

Celularity’s cell-therapy programs are capital intensive. Securing a single investor on standard terms suggests market confidence remains, yet the modest size affirms fundraising avenues may be constrained. With warrants struck below historical prices, future dilution is likely. From a strategic standpoint, proceeds should cover near-term R&D milestones, but additional raises are probable before pivotal trials. Impact is incremental rather than catalytic.

Celularity Inc. ha depositato un 8-K segnalando un collocamento privato effettuato il 14 luglio 2025 con un unico investitore istituzionale. La società venderà 1.230.769 azioni di Classe A più warrant abbinati con durata biennale a un prezzo combinato di 1,625 $ per unità, generando 2,0 milioni di dollari di proventi lordi. I warrant sono esercitabili immediatamente a 1,50 $ e, se esercitati completamente, potrebbero aggiungere circa 1,85 milioni di dollari in più.

I titoli vengono emessi ai sensi dell’esenzione Sezione 4(a)(2)/Regola 506(b) e pertanto sono non registrati. I proventi netti sono destinati a capitale circolante e scopi aziendali generali. Il Contratto di Acquisto e il Warrant includono dichiarazioni, garanzie e condizioni di chiusura consuete; i moduli completi sono allegati come Allegati 10.1 e 10.2.

L’emissione di azioni implica una diluizione stimata di circa 3-4% sulla base azionaria attuale, con ulteriore diluizione possibile in caso di esercizio dei warrant. Sebbene l’aumento rafforzi la liquidità a breve termine, la dimensione relativamente contenuta evidenzia la continua dipendenza di Celularity dal finanziamento esterno per portare avanti i suoi programmi di terapia cellulare derivata dalla placenta.

Celularity Inc. presentó un 8-K informando sobre una colocación privada realizada el 14 de julio de 2025 con un único inversor institucional. La compañía venderá 1.230.769 acciones Clase A más warrants a dos años a un precio combinado de $1.625 por unidad, generando $2.0 millones en ingresos brutos. Los warrants son ejercitables inmediatamente a $1.50 y, si se ejercen completamente, podrían añadir aproximadamente $1.85 millones adicionales.

Los valores se emiten bajo una exención de la Sección 4(a)(2)/Regla 506(b) y, por lo tanto, están no registrados. Los ingresos netos están destinados a capital de trabajo y fines corporativos generales. El Acuerdo de Compra y el Warrant incluyen representaciones, garantías y condiciones de cierre habituales; los formularios completos están adjuntos como Anexos 10.1 y 10.2.

La emisión de acciones implica una dilución estimada de aproximadamente 3-4% sobre la base accionaria actual, con una posible dilución adicional si se ejercen los warrants. Aunque la recaudación fortalece la liquidez a corto plazo, el tamaño relativamente pequeño destaca la continua dependencia de Celularity del financiamiento externo para avanzar en sus programas de terapia celular derivada de la placenta.

Celularity Inc.는 2025년 7월 14일 단일 기관 투자자와 체결한 사모 배정에 대해 8-K 보고서를 제출했습니다. 회사는 1,230,769주 클래스 A 주식과 2년 만기 워런트를 단위당 1.625달러의 결합 가격으로 판매하여 총 200만 달러의 총 수익을 창출할 예정입니다. 워런트는 즉시 행사 가능하며 행사 가격은 1.50달러이고, 전액 행사 시 약 185만 달러가 추가로 발생할 수 있습니다.

증권은 섹션 4(a)(2)/규칙 506(b) 면제에 따라 발행되며, 따라서 등록되지 않은 증권입니다. 순수익은 운영 자금 및 일반 기업 목적에 사용될 예정입니다. 매매 계약서와 워런트에는 일반적인 진술, 보증 및 종결 조건이 포함되어 있으며, 전체 양식은 부록 10.1 및 10.2에 첨부되어 있습니다.

이번 주식 발행은 현재 주식 기반 대비 약 3-4%의 희석 효과를 의미하며, 워런트 행사 시 추가 희석 가능성이 있습니다. 이번 자금 조달은 단기 유동성을 강화하지만, 비교적 소규모라는 점은 Celularity가 태반 유래 세포 치료 프로그램을 진행하기 위해 외부 자금 조달에 계속 의존하고 있음을 보여줍니다.

Celularity Inc. a déposé un 8-K rapportant un placement privé réalisé le 14 juillet 2025 avec un investisseur institutionnel unique. La société vendra 1 230 769 actions de Classe A ainsi que des bons de souscription assortis d’une durée de deux ans à un prix combiné de 1,625 $ par unité, générant 2,0 millions de dollars de produits bruts. Les bons de souscription sont immédiatement exerçables à 1,50 $ et, s’ils sont entièrement exercés, pourraient apporter environ 1,85 million de dollars supplémentaires.

Les titres sont émis dans le cadre d’une exemption Section 4(a)(2)/Règle 506(b) et sont donc non enregistrés. Les produits nets sont destinés au fonds de roulement et aux besoins généraux de l’entreprise. Le contrat d’achat et le bon de souscription comprennent des déclarations, garanties et conditions de clôture habituelles ; les formulaires complets sont joints en annexes 10.1 et 10.2.

L’émission d’actions implique une dilution estimée d’environ 3-4 % de la base actuelle d’actions, avec une dilution supplémentaire possible en cas d’exercice des bons de souscription. Bien que cette levée de fonds renforce la liquidité à court terme, sa taille relativement modeste souligne la dépendance continue de Celularity au financement externe pour faire avancer ses programmes de thérapie cellulaire dérivée du placenta.

Celularity Inc. hat am 14. Juli 2025 eine private Platzierung mit einem institutionellen Investor durchgeführt und dies in einem 8-K-Bericht gemeldet. Das Unternehmen verkauft 1.230.769 Class A Aktien sowie dazu passende zweijährige Warrants zu einem kombinierten Preis von 1,625 $ pro Einheit, was einen Bruttoerlös von 2,0 Millionen Dollar generiert. Die Warrants sind sofort ausübbar zu 1,50 $ und könnten bei vollständiger Ausübung etwa 1,85 Millionen Dollar zusätzlich einbringen.

Die Wertpapiere werden unter einer Section 4(a)(2)/Regel 506(b) Befreiung ausgegeben und sind daher nicht registriert. Die Nettoerlöse sind für Umlaufvermögen und allgemeine Unternehmenszwecke vorgesehen. Der Kaufvertrag und die Warrants enthalten übliche Zusicherungen, Gewährleistungen und Abschlussbedingungen; vollständige Formulare sind als Anlagen 10.1 und 10.2 beigefügt.

Die Aktienausgabe bedeutet eine geschätzte Verwässerung von etwa 3-4 % der aktuellen Aktienbasis, mit zusätzlicher Verwässerung bei Ausübung der Warrants. Obwohl die Kapitalerhöhung die kurzfristige Liquidität stärkt, verdeutlicht die relativ geringe Größe die anhaltende Abhängigkeit von Celularity von externer Finanzierung zur Weiterentwicklung seiner plazentabasierten Zelltherapieprogramme.

http://fasb.org/us-gaap/2025#ProductMemberhttp://fasb.org/us-gaap/2025#ProductMemberhttp://fasb.org/us-gaap/2025#ProductMember0000812074false--12-312025Q2http://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#ProductMemberhttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2025#OtherOperatingIncomeExpenseNet0000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-06-300000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-12-310000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-06-300000812074oi:SupplierFinanceProgramObligationsMember2025-04-012025-06-300000812074oi:SupplierFinanceProgramObligationsMember2025-01-012025-06-300000812074oi:SupplierFinanceProgramObligationsMember2024-04-012024-06-300000812074oi:SupplierFinanceProgramObligationsMember2024-01-012024-06-300000812074oi:SupplierFinanceProgramObligationsMember2025-06-300000812074oi:SupplierFinanceProgramObligationsMember2025-03-310000812074oi:SupplierFinanceProgramObligationsMember2024-12-310000812074oi:SupplierFinanceProgramObligationsMember2024-06-300000812074oi:SupplierFinanceProgramObligationsMember2024-03-310000812074oi:SupplierFinanceProgramObligationsMember2023-12-310000812074us-gaap:TreasuryStockCommonMember2025-04-012025-06-300000812074us-gaap:TreasuryStockCommonMember2024-04-012024-06-300000812074us-gaap:TreasuryStockCommonMember2025-01-012025-06-300000812074us-gaap:TreasuryStockCommonMember2024-01-012024-06-300000812074us-gaap:TreasuryStockCommonMember2025-06-300000812074us-gaap:RetainedEarningsMember2025-06-300000812074us-gaap:NoncontrollingInterestMember2025-06-300000812074us-gaap:CommonStockMember2025-06-300000812074us-gaap:AdditionalPaidInCapitalMember2025-06-300000812074us-gaap:AccumulatedTranslationAdjustmentMember2025-06-300000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-06-300000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-06-300000812074us-gaap:TreasuryStockCommonMember2025-03-310000812074us-gaap:RetainedEarningsMember2025-03-310000812074us-gaap:NoncontrollingInterestMember2025-03-310000812074us-gaap:CommonStockMember2025-03-310000812074us-gaap:AdditionalPaidInCapitalMember2025-03-310000812074us-gaap:AccumulatedTranslationAdjustmentMember2025-03-310000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-03-310000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-03-310000812074us-gaap:TreasuryStockCommonMember2024-12-310000812074us-gaap:RetainedEarningsMember2024-12-310000812074us-gaap:NoncontrollingInterestMember2024-12-310000812074us-gaap:CommonStockMember2024-12-310000812074us-gaap:AdditionalPaidInCapitalMember2024-12-310000812074us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-12-310000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310000812074us-gaap:TreasuryStockCommonMember2024-06-300000812074us-gaap:RetainedEarningsMember2024-06-300000812074us-gaap:NoncontrollingInterestMember2024-06-300000812074us-gaap:CommonStockMember2024-06-300000812074us-gaap:AdditionalPaidInCapitalMember2024-06-300000812074us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-06-300000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-06-300000812074us-gaap:TreasuryStockCommonMember2024-03-310000812074us-gaap:RetainedEarningsMember2024-03-310000812074us-gaap:NoncontrollingInterestMember2024-03-310000812074us-gaap:CommonStockMember2024-03-310000812074us-gaap:AdditionalPaidInCapitalMember2024-03-310000812074us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-310000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-03-310000812074us-gaap:TreasuryStockCommonMember2023-12-310000812074us-gaap:RetainedEarningsMember2023-12-310000812074us-gaap:NoncontrollingInterestMember2023-12-310000812074us-gaap:CommonStockMember2023-12-310000812074us-gaap:AdditionalPaidInCapitalMember2023-12-310000812074us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-310000812074us-gaap:PensionPlansDefinedBenefitMember2025-01-012025-06-300000812074us-gaap:CorporateNonSegmentMember2025-04-012025-06-300000812074us-gaap:CorporateNonSegmentMember2025-01-012025-06-300000812074us-gaap:CorporateNonSegmentMember2024-04-012024-06-300000812074us-gaap:CorporateNonSegmentMember2024-01-012024-06-300000812074oi:NonalcoholicBeverageMemberoi:EuropeSegmentMember2025-04-012025-06-300000812074oi:NonalcoholicBeverageMemberoi:AmericasSegmentMember2025-04-012025-06-300000812074oi:FoodAndOtherMemberoi:EuropeSegmentMember2025-04-012025-06-300000812074oi:FoodAndOtherMemberoi:AmericasSegmentMember2025-04-012025-06-300000812074oi:AlcoholicBeveragesMemberoi:EuropeSegmentMember2025-04-012025-06-300000812074oi:AlcoholicBeveragesMemberoi:AmericasSegmentMember2025-04-012025-06-300000812074us-gaap:NonUsMember2025-04-012025-06-300000812074oi:ReportableSegmentMember2025-04-012025-06-300000812074oi:NonalcoholicBeverageMember2025-04-012025-06-300000812074oi:FoodAndOtherMember2025-04-012025-06-300000812074oi:AlcoholicBeveragesMember2025-04-012025-06-300000812074country:US2025-04-012025-06-300000812074oi:NonalcoholicBeverageMemberoi:EuropeSegmentMember2025-01-012025-06-300000812074oi:NonalcoholicBeverageMemberoi:AmericasSegmentMember2025-01-012025-06-300000812074oi:FoodAndOtherMemberoi:EuropeSegmentMember2025-01-012025-06-300000812074oi:FoodAndOtherMemberoi:AmericasSegmentMember2025-01-012025-06-300000812074oi:AlcoholicBeveragesMemberoi:EuropeSegmentMember2025-01-012025-06-300000812074oi:AlcoholicBeveragesMemberoi:AmericasSegmentMember2025-01-012025-06-300000812074us-gaap:NonUsMember2025-01-012025-06-300000812074oi:ReportableSegmentMember2025-01-012025-06-300000812074oi:NonalcoholicBeverageMember2025-01-012025-06-300000812074oi:FoodAndOtherMember2025-01-012025-06-300000812074oi:AlcoholicBeveragesMember2025-01-012025-06-300000812074country:US2025-01-012025-06-300000812074oi:NonalcoholicBeverageMemberoi:EuropeSegmentMember2024-04-012024-06-300000812074oi:NonalcoholicBeverageMemberoi:AmericasSegmentMember2024-04-012024-06-300000812074oi:FoodAndOtherMemberoi:EuropeSegmentMember2024-04-012024-06-300000812074oi:FoodAndOtherMemberoi:AmericasSegmentMember2024-04-012024-06-300000812074oi:AlcoholicBeveragesMemberoi:EuropeSegmentMember2024-04-012024-06-300000812074oi:AlcoholicBeveragesMemberoi:AmericasSegmentMember2024-04-012024-06-300000812074us-gaap:NonUsMember2024-04-012024-06-300000812074us-gaap:AllOtherSegmentsMember2024-04-012024-06-300000812074oi:ReportableSegmentMember2024-04-012024-06-300000812074oi:NonalcoholicBeverageMember2024-04-012024-06-300000812074oi:FoodAndOtherMember2024-04-012024-06-300000812074oi:AlcoholicBeveragesMember2024-04-012024-06-300000812074country:US2024-04-012024-06-300000812074oi:NonalcoholicBeverageMemberoi:EuropeSegmentMember2024-01-012024-06-300000812074oi:NonalcoholicBeverageMemberoi:AmericasSegmentMember2024-01-012024-06-300000812074oi:FoodAndOtherMemberoi:EuropeSegmentMember2024-01-012024-06-300000812074oi:FoodAndOtherMemberoi:AmericasSegmentMember2024-01-012024-06-300000812074oi:AlcoholicBeveragesMemberoi:EuropeSegmentMember2024-01-012024-06-300000812074oi:AlcoholicBeveragesMemberoi:AmericasSegmentMember2024-01-012024-06-300000812074us-gaap:NonUsMember2024-01-012024-06-300000812074us-gaap:AllOtherSegmentsMember2024-01-012024-06-300000812074oi:ReportableSegmentMember2024-01-012024-06-300000812074oi:NonalcoholicBeverageMember2024-01-012024-06-300000812074oi:FoodAndOtherMember2024-01-012024-06-300000812074oi:AlcoholicBeveragesMember2024-01-012024-06-300000812074country:US2024-01-012024-06-300000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2025-06-300000812074us-gaap:EmployeeSeveranceMemberoi:FitToWinRestructuringProgramMember2025-06-300000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2025-06-300000812074oi:OtherExitCostsMemberoi:FitToWinRestructuringProgramMember2025-06-300000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2025-03-310000812074us-gaap:EmployeeSeveranceMemberoi:FitToWinRestructuringProgramMember2025-03-310000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2025-03-310000812074oi:OtherExitCostsMemberoi:FitToWinRestructuringProgramMember2025-03-3100008120742025-03-310000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2024-12-310000812074us-gaap:EmployeeSeveranceMemberoi:FitToWinRestructuringProgramMember2024-12-310000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2024-12-310000812074oi:OtherExitCostsMemberoi:FitToWinRestructuringProgramMember2024-12-310000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2024-06-300000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2024-06-300000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2024-03-310000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2024-03-3100008120742024-03-310000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2023-12-310000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2023-12-310000812074us-gaap:AllOtherSegmentsMember2025-04-012025-06-300000812074us-gaap:AllOtherSegmentsMember2025-01-012025-06-300000812074oi:FitToWinRestructuringProgramMemberoi:AmericasSegmentMemberus-gaap:SubsequentEventMember2025-09-300000812074us-gaap:RetainedEarningsMember2025-04-012025-06-300000812074us-gaap:RetainedEarningsMember2025-01-012025-06-300000812074us-gaap:RetainedEarningsMember2024-04-012024-06-300000812074us-gaap:RetainedEarningsMember2024-01-012024-06-300000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-04-012024-06-300000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2025-04-012025-06-300000812074us-gaap:EmployeeSeveranceMemberoi:FitToWinRestructuringProgramMember2025-04-012025-06-300000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2025-04-012025-06-300000812074oi:OtherExitCostsMemberoi:FitToWinRestructuringProgramMember2025-04-012025-06-300000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2025-01-012025-06-300000812074us-gaap:EmployeeSeveranceMemberoi:FitToWinRestructuringProgramMember2025-01-012025-06-300000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2025-01-012025-06-300000812074oi:OtherExitCostsMemberoi:FitToWinRestructuringProgramMember2025-01-012025-06-300000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2024-04-012024-06-300000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2024-04-012024-06-300000812074us-gaap:EmployeeSeveranceMemberoi:OtherRestructuringPlansMember2024-01-012024-06-300000812074oi:OtherExitCostsMemberoi:OtherRestructuringPlansMember2024-01-012024-06-300000812074us-gaap:NoncontrollingInterestMember2024-04-012024-06-300000812074us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2025-04-012025-06-300000812074us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2025-01-012025-06-300000812074us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2024-04-012024-06-300000812074us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2024-01-012024-06-300000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2025-04-012025-06-300000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2025-01-012025-06-300000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-01-012024-06-300000812074us-gaap:DesignatedAsHedgingInstrumentMember2025-04-012025-06-300000812074us-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-06-300000812074us-gaap:DesignatedAsHedgingInstrumentMember2024-04-012024-06-300000812074us-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-06-300000812074us-gaap:AccumulatedTranslationAdjustmentMember2025-04-012025-06-300000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-04-012025-06-300000812074us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-06-300000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-06-300000812074us-gaap:AccumulatedTranslationAdjustmentMember2024-04-012024-06-300000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000812074us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-06-300000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-06-300000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-04-012025-06-300000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-06-300000812074us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-04-012024-06-300000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-04-012024-06-300000812074us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300000812074us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-06-300000812074us-gaap:NonUsMember2025-06-300000812074country:US2025-06-300000812074us-gaap:NonUsMember2024-06-300000812074country:US2024-06-300000812074us-gaap:NoncontrollingInterestMember2025-04-012025-06-300000812074us-gaap:NoncontrollingInterestMember2025-01-012025-06-300000812074us-gaap:NoncontrollingInterestMember2024-01-012024-06-300000812074oi:CuyahogaValleyNationalParkMember2025-06-300000812074oi:CuyahogaValleyNationalParkMemberus-gaap:SubsequentEventMember2025-09-300000812074oi:SuperfundSitesMember2025-06-300000812074oi:SuperfundSitesMember2024-12-310000812074oi:SuperfundSitesMember2024-06-300000812074oi:SecuredCreditAgreementRevolvingLoansMember2025-06-300000812074oi:OtherDebtMember2025-06-300000812074oi:FinanceLeaseMember2025-06-300000812074oi:SeniorNotes7375PercentDue2032Member2024-12-310000812074oi:SeniorNotes7.250Due2031Member2024-12-310000812074oi:SeniorNotes6625PercentDue2027Member2024-12-310000812074oi:SeniorNotes6.250Due2028Member2024-12-310000812074oi:SeniorNotes5375PercentDue2025Member2024-12-310000812074oi:SeniorNotes5250PercentDue2029Member2024-12-310000812074oi:SeniorNotes4.750Due2030Member2024-12-310000812074oi:SeniorNotes2875PercentDue2025Member2024-12-310000812074oi:SecuredCreditAgreementTermLoanMember2024-12-310000812074oi:OtherDebtMember2024-12-310000812074oi:FinanceLeaseMember2024-12-310000812074oi:SeniorNotes7375PercentDue2032Member2024-06-300000812074oi:SeniorNotes7.250Due2031Member2024-06-300000812074oi:SeniorNotes6625PercentDue2027Member2024-06-300000812074oi:SeniorNotes6.250Due2028Member2024-06-300000812074oi:SeniorNotes5375PercentDue2025Member2024-06-300000812074oi:SeniorNotes5250PercentDue2029Member2024-06-300000812074oi:SeniorNotes4.750Due2030Member2024-06-300000812074oi:SeniorNotes3125PercentDue2024Member2024-06-300000812074oi:SeniorNotes2875PercentDue2025Member2024-06-300000812074oi:SecuredCreditAgreementTermLoanMember2024-06-300000812074oi:OtherDebtMember2024-06-300000812074oi:FinanceLeaseMember2024-06-300000812074oi:CuyahogaValleyNationalParkMemberus-gaap:OtherExpenseMember2025-01-012025-03-310000812074us-gaap:SecuredDebtMember2025-06-300000812074us-gaap:RevolvingCreditFacilityMember2025-06-300000812074oi:SecuredCreditAgreementTermLoanMember2025-06-300000812074oi:MulticurrencyRevolvingCreditFacilityMember2025-06-300000812074oi:AggregateTermLoansMember2022-08-300000812074oi:DelayedDrawTermLoanFacilityMember2022-03-2500008120742022-03-250000812074us-gaap:NonUsMember2025-01-012025-06-300000812074country:US2025-01-012025-06-300000812074us-gaap:NonUsMember2024-01-012024-06-300000812074country:US2024-01-012024-06-300000812074us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-04-012025-06-300000812074us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-01-012025-06-300000812074us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-04-012024-06-300000812074us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-01-012024-06-300000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-06-300000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000812074us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-06-300000812074oi:NetInvestmentHedgesMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-06-300000812074oi:ForeignExchangeRiskMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-06-300000812074us-gaap:DesignatedAsHedgingInstrumentMember2025-06-300000812074us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-12-310000812074oi:NetInvestmentHedgesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000812074oi:ForeignExchangeRiskMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000812074us-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000812074us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-06-300000812074oi:NetInvestmentHedgesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000812074oi:ForeignExchangeRiskMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000812074us-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000812074oi:ForeignExchangeRiskMemberoi:FairValueHedgesMember2025-01-012025-06-300000812074oi:ForeignExchangeRiskMemberoi:FairValueHedgesMember2024-01-012024-12-310000812074oi:ForeignExchangeRiskMemberoi:FairValueHedgesMember2024-01-012024-06-300000812074us-gaap:OperatingSegmentsMemberoi:EuropeSegmentMember2025-04-012025-06-300000812074us-gaap:OperatingSegmentsMemberoi:AmericasSegmentMember2025-04-012025-06-300000812074us-gaap:OperatingSegmentsMember2025-04-012025-06-300000812074oi:CorporateAndReconcilingItemsMember2025-04-012025-06-300000812074us-gaap:OperatingSegmentsMemberoi:EuropeSegmentMember2025-01-012025-06-300000812074us-gaap:OperatingSegmentsMemberoi:AmericasSegmentMember2025-01-012025-06-300000812074us-gaap:OperatingSegmentsMember2025-01-012025-06-300000812074oi:CorporateAndReconcilingItemsMember2025-01-012025-06-300000812074us-gaap:OperatingSegmentsMemberoi:EuropeSegmentMember2024-04-012024-06-300000812074us-gaap:OperatingSegmentsMemberoi:AmericasSegmentMember2024-04-012024-06-300000812074us-gaap:OperatingSegmentsMember2024-04-012024-06-300000812074oi:CorporateAndReconcilingItemsMember2024-04-012024-06-300000812074us-gaap:OperatingSegmentsMemberoi:EuropeSegmentMember2024-01-012024-06-300000812074us-gaap:OperatingSegmentsMemberoi:AmericasSegmentMember2024-01-012024-06-300000812074us-gaap:OperatingSegmentsMember2024-01-012024-06-300000812074oi:CorporateAndReconcilingItemsMember2024-01-012024-06-300000812074us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2025-04-012025-06-300000812074country:USus-gaap:PensionPlansDefinedBenefitMember2025-04-012025-06-300000812074us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2025-01-012025-06-300000812074country:USus-gaap:PensionPlansDefinedBenefitMember2025-01-012025-06-300000812074us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-04-012024-06-300000812074country:USus-gaap:PensionPlansDefinedBenefitMember2024-04-012024-06-300000812074us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-06-300000812074country:USus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-06-300000812074us-gaap:LineOfCreditMember2025-06-300000812074oi:SeniorNotes5375PercentDue2025Member2025-06-300000812074oi:SeniorNotes3125PercentDue2024Member2025-06-300000812074oi:SeniorNotes2875PercentDue2025Member2025-06-300000812074oi:SeniorNotes2875PercentDue2025Member2025-03-310000812074oi:SeniorNotes6375PercentDue2025Member2024-05-310000812074oi:SeniorNotes2875PercentDue2025Member2024-05-310000812074oi:SeniorNotes7375PercentDue2032Member2024-05-310000812074oi:SeniorNotes5250PercentDue2029Member2024-05-310000812074srt:MinimumMemberus-gaap:SecuredDebtMember2025-01-012025-06-300000812074oi:EuropeSegmentMember2025-04-012025-06-300000812074oi:AmericasSegmentMember2025-04-012025-06-300000812074oi:EuropeSegmentMember2025-01-012025-06-300000812074oi:AmericasSegmentMember2025-01-012025-06-300000812074oi:EuropeSegmentMember2024-04-012024-06-300000812074oi:AmericasSegmentMember2024-04-012024-06-300000812074oi:EuropeSegmentMember2024-01-012024-06-300000812074oi:AmericasSegmentMember2024-01-012024-06-3000008120742023-12-310000812074us-gaap:OperatingSegmentsMemberoi:EuropeSegmentMember2025-06-300000812074us-gaap:OperatingSegmentsMemberoi:AmericasSegmentMember2025-06-300000812074us-gaap:OperatingSegmentsMember2025-06-300000812074oi:CorporateAndReconcilingItemsMember2025-06-300000812074us-gaap:OperatingSegmentsMemberoi:EuropeSegmentMember2024-06-300000812074us-gaap:OperatingSegmentsMemberoi:AmericasSegmentMember2024-06-300000812074us-gaap:OperatingSegmentsMember2024-06-300000812074oi:CorporateAndReconcilingItemsMember2024-06-300000812074us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300000812074us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300000812074us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000812074us-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-3000008120742024-05-140000812074oi:FitToWinRestructuringProgramMemberoi:AmericasSegmentMemberus-gaap:SubsequentEventMember2025-07-012025-09-300000812074oi:AssetImpairmentMemberoi:FitToWinRestructuringProgramMember2025-04-012025-06-300000812074oi:AssetImpairmentMemberoi:FitToWinRestructuringProgramMember2025-01-012025-06-300000812074srt:MaximumMemberus-gaap:SecuredDebtMember2025-01-012025-06-300000812074country:MX2025-04-012025-06-300000812074country:IT2025-04-012025-06-300000812074country:FR2025-04-012025-06-300000812074country:MX2025-01-012025-06-300000812074country:IT2025-01-012025-06-300000812074country:FR2025-01-012025-06-300000812074country:MX2024-04-012024-06-300000812074country:IT2024-04-012024-06-300000812074country:FR2024-04-012024-06-300000812074country:MX2024-01-012024-06-300000812074country:IT2024-01-012024-06-300000812074country:FR2024-01-012024-06-300000812074oi:FitToWinRestructuringProgramMemberoi:AmericasSegmentMemberus-gaap:SubsequentEventMember2025-07-012025-07-310000812074oi:FitToWinRestructuringProgramMember2025-04-012025-06-300000812074oi:FitToWinRestructuringProgramMember2025-01-012025-06-300000812074oi:AntiCompetitionMember2023-11-300000812074us-gaap:OtherExpenseMemberoi:FitToWinRestructuringProgramMember2025-01-012025-06-300000812074oi:SeniorNotes7375PercentDue2032Member2025-06-300000812074oi:SeniorNotes7.250Due2031Member2025-06-300000812074oi:SeniorNotes6625PercentDue2027Member2025-06-300000812074oi:SeniorNotes6.250Due2028Member2025-06-300000812074oi:SeniorNotes5250PercentDue2029Member2025-06-300000812074oi:SeniorNotes4.750Due2030Member2025-06-300000812074us-gaap:SecuredDebtMember2025-01-012025-06-300000812074srt:MinimumMemberus-gaap:SecuredDebtMember2025-06-300000812074srt:MaximumMemberus-gaap:SecuredDebtMember2025-06-3000008120742024-12-3100008120742024-06-300000812074oi:ForeignExchangeRiskMemberus-gaap:CashFlowHedgingMember2025-06-300000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:CashFlowHedgingMember2025-06-300000812074oi:ForeignExchangeRiskMemberus-gaap:CashFlowHedgingMember2024-12-310000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:CashFlowHedgingMember2024-12-310000812074oi:ForeignExchangeRiskMemberus-gaap:CashFlowHedgingMember2024-06-300000812074oi:CommodityForwardContractsAndCollarsMemberus-gaap:CashFlowHedgingMember2024-06-3000008120742024-01-012024-06-3000008120742024-04-012024-06-3000008120742025-04-012025-06-3000008120742025-06-3000008120742025-01-012025-06-30iso4217:USDutr:Btuxbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:sharesoi:agreementoi:itemoi:Plantiso4217:EURoi:segment

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark one)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended

June 30, 2025

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-9576

Graphic

O-I GLASS, INC.

(Exact name of registrant as specified in its charter)

Delaware

22-2781933

(State or other jurisdiction of

(IRS Employer

incorporation or organization)

Identification No.)

One Michael Owens Way, Perrysburg, Ohio

43551

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (567) 336-5000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol

Name of each exchange on which registered

Common Stock, par value $.01 per share

OI

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

The number of shares of common stock, par value $.01, of O-I Glass, Inc. outstanding as of June 30, 2025 was 154,073,257.

Part I — FINANCIAL INFORMATION

Item 1. Financial Statements.

The Condensed Consolidated Financial Statements of O-I Glass, Inc. (the “Company”) presented herein are unaudited but, in the opinion of management, reflect all adjustments necessary to present fairly such information for the periods and at the dates indicated. All adjustments are of a normal recurring nature. Because the following unaudited Condensed Consolidated Financial Statements have been prepared in accordance with Article 10 of Regulation S-X, they do not contain all information and footnotes normally contained in annual consolidated financial statements; accordingly, they should be read in conjunction with the Consolidated Financial Statements and notes thereto appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

1

O-I GLASS, INC.

CONDENSED CONSOLIDATED RESULTS OF OPERATIONS

(Dollars in millions, except per share amounts)
(Unaudited)

Three months ended

Six months ended

June 30,

June 30,

2025

    

2024

    

2025

    

2024

    

 

Net sales

$

1,706

$

1,729

$

3,273

$

3,322

Cost of goods sold

 

(1,407)

 

(1,426)

 

(2,694)

 

(2,701)

Gross profit

 

299

303

579

621

Selling and administrative expense

 

(106)

(110)

(213)

(233)

Research, development and engineering expense

 

(11)

(20)

(25)

(42)

Interest expense, net

 

(85)

(87)

(166)

(165)

Equity earnings

 

28

30

51

55

Other expense, net

 

(118)

(12)

(200)

(15)

Earnings before income taxes

 

7

 

104

 

26

 

221

Provision for income taxes

 

(6)

(42)

(36)

(83)

Net earnings (loss)

 

1

 

62

 

(10)

 

138

Net earnings attributable to non-controlling interests

 

(6)

(5)

(10)

(9)

Net earnings (loss) attributable to the Company

$

(5)

$

57

$

(20)

$

129

Basic earnings per share:

Net earnings (loss) attributable to the Company

$

(0.03)

$

0.37

$

(0.13)

$

0.83

Weighted average shares outstanding (thousands)

153,993

155,280

153,851

154,777

Diluted earnings per share:

Net earnings (loss) attributable to the Company

$

(0.03)

$

0.36

$

(0.13)

$

0.81

Weighted average diluted shares outstanding (thousands)

153,993

157,382

153,851

157,925

See accompanying notes.

2

O-I GLASS, INC.

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME (LOSS)

(Dollars in millions)

(Unaudited)

Three months ended

Six months ended

June 30,

June 30,

    

2025

    

2024

    

2025

    

2024

    

 

Net earnings (loss)

$

1

$

62

$

(10)

$

138

Other comprehensive income (loss):

Foreign currency translation adjustments

 

213

(257)

310

(252)

Pension and other postretirement benefit adjustments, net of tax

 

(7)

6

(10)

12

Change in fair value of derivative instruments, net of tax

 

(77)

10

(105)

19

Other comprehensive income (loss)

129

(241)

195

(221)

Total comprehensive income (loss)

130

(179)

185

(83)

Comprehensive (income) loss attributable to non-controlling interests

 

(6)

2

(15)

(2)

Comprehensive income (loss) attributable to the Company

$

124

$

(177)

$

170

$

(85)

See accompanying notes.

3

O-I GLASS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in millions)

(Unaudited)

June 30,

December 31,

June 30,

2025

2024

2024

Assets

Current assets:

Cash and cash equivalents

$

487

$

734

$

671

Trade receivables, net of allowance of $31 million, $30 million, and $30 million at June 30, 2025, December 31, 2024 and June 30, 2024

 

848

 

572

 

725

Inventories

 

990

 

963

 

1,153

Prepaid expenses and other current assets

 

279

 

209

 

270

Total current assets

 

2,604

 

2,478

 

2,819

Property, plant and equipment, net

3,458

3,296

3,465

Goodwill

1,467

1,321

1,395

Intangibles, net

196

198

226

Other assets

1,454

1,361

1,429

Total assets

$

9,179

$

8,654

$

9,334

Liabilities and share owners’ equity

Current liabilities:

Accounts payable

$

1,104

$

1,142

$

1,127

Short-term loans and long-term debt due within one year

236

416

500

Other liabilities

762

602

607

Total current liabilities

 

2,102

 

2,160

 

2,234

Long-term debt

4,898

4,553

4,648

Other long-term liabilities

810

736

821

Share owners' equity

1,369

1,205

1,631

Total liabilities and share owners’ equity

$

9,179

$

8,654

$

9,334

See accompanying notes.

4

O-I GLASS, INC.

CONDENSED CONSOLIDATED CASH FLOWS

(Dollars in millions)

(Unaudited)

Six months ended June 30,

    

2025

    

2024

 

 

Cash flows from operating activities:

Net earnings (loss)

$

(10)

$

138

Non-cash charges

Depreciation and amortization

 

238

250

Pension expense

 

15

16

Stock-based compensation expense

8

6

Restructuring, asset impairment and related charges

 

195

Legacy environmental charge

4

10

Gain on sale of miscellaneous assets

(6)

Cash payments

Pension contributions

 

(14)

(9)

Cash paid for restructuring activities

 

(78)

(15)

Change in components of working capital

 

(335)

(439)

Other, net (a)

(33)

23

Cash utilized in operating activities

 

(16)

 

(20)

Cash flows from investing activities:

Cash payments for property, plant and equipment

 

(239)

(373)

Net cash proceeds on sale of misc. assets

18

6

Net cash payments from hedging activities

(13)

Cash utilized in investing activities

 

(221)

 

(380)

Cash flows from financing activities:

Additions to long-term debt

680

1,096

Repayments of long-term debt

(698)

(917)

Increase in short-term loans

12

54

Payment of finance fees

(11)

Shares repurchased

(20)

(20)

Net cash payments for hedging activity

(6)

Distributions to non-controlling interests

(8)

(9)

Other, net(b)

(7)

(13)

Cash provided by (utilized in) financing activities

 

(47)

 

180

Effect of exchange rate fluctuations on cash

 

37

(22)

Change in cash

 

(247)

 

(242)

Cash at beginning of period

 

734

913

Cash at end of period

$

487

$

671

(a)Other, net includes other non-cash charges plus other changes in non-current assets and liabilities.
(b)Other, net includes share settlement activity.

See accompanying notes.

5

O-I GLASS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Tabular data dollars in millions, except per share amounts

1. Segment Information

The Company has two reportable segments and two operating segments based on its geographic locations: the Americas and Europe. These two segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. Certain assets and activities not directly related to one of the segments or to glass manufacturing are reported within Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, certain equity investments and certain minor businesses in the Asia Pacific region. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments.

The Company’s measure of profit for its reportable segments is segment operating profit, which is a non-GAAP financial measure that consists of consolidated earnings before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations and other adjustments, as well as certain retained corporate costs. The Company’s management, including the chief operating decision maker (defined as the Chief Executive Officer), uses segment operating profit, supplemented by net sales and selected cash flow information, to evaluate segment performance and allocate resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided. Segment operating profit is not a recognized term under accounting principles generally accepted in the United States (“U.S. GAAP”) and, therefore, does not purport to be an alternative to earnings (loss) before income taxes. Further, the Company’s measure of segment operating profit may not be comparable to similarly titled measures used by other companies.

In accordance with ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” the Company has disclosed significant segment expenses reviewed by its chief operating decision maker. Other segment expenses (income) includes intangible amortization expense (Americas only), foreign currency exchange gains or losses, certain overhead expenses and other gains or losses. Certain prior year presentations have been recast below to conform to these new reporting requirements.

6

Financial information for the three months ended June 30, 2025 and 2024 regarding the Company’s reportable segments is as follows, as well as a reconciliation of segment operating profit to earnings before income taxes:

Three months ended June 30,

    

2025

    

2024

Americas

Europe

Total

Americas

Europe

Total

Reportable segment net sales

$

943

$

741

$

1,684

$

899

$

802

$

1,701

Other

22

28

Net Sales

 

 

 

1,706

$

1,729

Less:

Cost of goods sold

772

615

758

642

Selling, administrative, engineering and research and development expenses

42

46

47

46

Equity earnings

(19)

(9)

(16)

(13)

Other segment expenses (income)

13

(1)

4

Segment operating profit

$

135

$

90

$

225

$

106

$

127

$

233

Items excluded from segment operating profit:

Reconciliation of segment operating profit

Retained corporate costs and other

(25)

(32)

Restructuring, asset impairment and other charges

(108)

Legacy environmental charge

(10)

Interest expense, net

(85)

(87)

Earnings before income taxes

$

7

$

104

Financial information for the six months ended June 30, 2025 and 2024 regarding the Company’s reportable segments is as follows, as well as a reconciliation of segment operating profit to earnings before income taxes:

Six months ended June 30,

    

2025

    

2024

Americas

Europe

Total

Americas

Europe

Total

Reportable segment net sales

$

1,816

$

1,407

$

3,223

$

1,753

$

1,511

$

3,264

Other

50

58

Net Sales

 

 

 

3,273

$

3,322

Less:

Cost of goods sold

1,475

1,173

1,470

1,177

Selling, administrative, engineering and research and development expenses

85

92

99

93

Equity earnings

(38)

(13)

(35)

(19)

Other segment expenses (income)

18

(3)

11

Segment operating profit

$

276

$

158

$

434

$

208

$

260

$

468

Items excluded from segment operating profit:

Reconciliation of segment operating profit

Retained corporate costs and other

(53)

(72)

Restructuring, asset impairment and other charges

(191)

Legacy environmental charge

(4)

(10)

Gain on sale of miscellaneous assets

6

Interest expense, net

(166)

(165)

Earnings before income taxes

$

26

$

221

7

As of June 30,

    

    

    

Reportable

    

Retained

    

Consoli-

 

Segment

Corp Costs

dated

 

Americas

Europe

Totals

and Other

Totals

 

Total assets:

2025

$

4,841

$

3,984

$

8,825

$

354

$

9,179

2024

5,009

3,796

8,805

529

9,334

Equity investments:

2025

$

475

$

201

$

676

$

36

$

712

2024

467

173

640

58

698

Three months ended June 30,

    

    

    

Reportable

    

Retained

    

Consoli-

Segment

Corp Costs

dated

Americas

Europe

Totals

and Other

Totals

Equity earnings:

2025

$

19

$

9

$

28

$

$

28

2024

16

13

29

1

30

Capital expenditures:

2025

$

41

$

48

$

89

$

15

$

104

2024

99

58

157

3

160

Depreciation and amortization expense:

2025

$

70

$

43

$

113

$

5

$

118

2024

73

44

117

5

122

Six months ended June 30,

    

    

    

Reportable

    

Retained

    

Consoli-

Segment

Corp Costs

dated

Americas

Europe

Totals

and Other

Totals

Equity earnings:

2025

$

38

$

13

$

51

$

$

51

2024

35

19

54

1

55

Capital expenditures:

2025

$

103

$

120

$

223

$

16

$

239

2024

222

146

368

5

373

Depreciation and amortization expense:

2025

$

143

$

80

$

223

$

10

$

233

2024

148

87

235

10

245

The Company’s tangible long-lived assets, including property, plant and equipment and operating lease right-of-use assets, by geographic region are as follows:

As of June 30,

    

U.S.

    

Non-U.S.

    

Total

 

2025

$

798

$

2,854

$

3,652

2024

 

912

2,763

3,675

8

The Company’s net sales by geographic region are as follows:

Three months ended June 30,

    

U.S.

    

Non-U.S.

    

Total

 

2025

$

446

$

1,260

$

1,706

2024

 

419

1,310

1,729

Operations outside the U.S. that accounted for 10% or more of consolidated net sales during the three months ended June 30, 2025 and 2024 were in France (2025-12%, 2024-12%), Italy (2025-13%, 2024-13%), and Mexico (2025-14%, 2024-14%).

Six months ended June 30,

    

U.S.

    

Non-U.S.

    

Total

2025

$

888

$

2,385

$

3,273

2024

 

814

2,508

3,322

Operations outside the U.S. that accounted for 10% or more of consolidated net sales during the six months ended June 30, 2025 and 2024 were in France (2025-12%, 2024-12%), Italy (2025-13%, 2024-13%), and Mexico (2025-13%, 2024-14%).

2. Revenue

Revenue is recognized at a point in time when obligations under the terms of the Company’s contracts and related purchase orders with its customers are satisfied. This occurs with the transfer of control of glass containers, which primarily takes place when products are shipped from the Company’s manufacturing or warehousing facilities to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimated provisions for rebates, discounts, returns and allowances. Amounts billed to customers related to shipping and handling or other pass-through items are included in net sales in the Condensed Consolidated Results of Operations. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s payment terms are based on customary business practices and can vary by customer type. The term between invoicing and when payment is due is not significant. Also, the Company elected to account for shipping and handling costs as a fulfillment cost at the time of shipment.

For the three- and six-month periods ended June 30, 2025 and 2024, the Company had no material bad debt expense, and there were no material contract assets, contract liabilities or deferred contract costs recorded in the Condensed Consolidated Balance Sheets. For the three- and six-month periods ended June 30, 2025 and 2024, revenue recognized from prior periods was not material.

The following tables for the three months ended June 30, 2025 and 2024 disaggregate the Company’s revenue by customer end use:

Three months ended June 30, 2025

    

Americas

Europe

Total

Alcoholic beverages (beer, wine, spirits)

 

$

535

 

$

533

 

$

1,068

Food and other

 

219

 

118

 

337

Non-alcoholic beverages

 

189

 

90

 

279

Reportable segment totals

$

943

$

741

$

1,684

Other

 

22

Net sales

 

$

1,706

9

Three months ended June 30, 2024

    

Americas

Europe

Total

Alcoholic beverages (beer, wine, spirits)

 

$

494

$

600

$

1,094

Food and other

 

220

116

 

336

Non-alcoholic beverages

 

185

86

 

271

Reportable segment totals

$

899

$

802

$

1,701

Other

 

28

Net sales

 

$

1,729

The following tables for the six months ended June 30, 2025 and 2024 disaggregate the Company’s revenue by customer end use:

Six months ended June 30, 2025

    

Americas

Europe

Total

Alcoholic beverages (beer, wine, spirits)

 

$

1,038

 

$

1,014

$

2,052

Food and other

 

436

 

229

 

665

Non-alcoholic beverages

 

342

 

164

 

506

Reportable segment totals

$

1,816

$

1,407

$

3,223

Other

 

50

Net sales

 

$

3,273

Six months ended June 30, 2024

    

Americas

Europe

Total

Alcoholic beverages (beer, wine, spirits)

 

$

963

$

1,117

$

2,080

Food and other

 

433

236

 

669

Non-alcoholic beverages

 

357

158

 

515

Reportable segment totals

$

1,753

$

1,511

$

3,264

Other

 

58

Net sales

 

$

3,322

3. Credit Losses

The Company is exposed to credit losses primarily through its sales of glass containers to customers. The Company’s trade receivables from customers are due within one year or less. The Company assesses each customer’s ability to pay for the glass containers it sells to them by conducting a credit review. The credit review considers the expected billing exposure and timing for payment and the customer’s established credit rating or the Company’s assessment of the customer’s creditworthiness, based on an analysis of their financial statements when a credit rating is not available. The Company also considers contract terms and conditions, country and political risk, and business strategy in its evaluation. A credit limit is established for each customer based on the outcome of this review. The Company may require collateralized asset support or a prepayment to mitigate credit risk. The Company monitors its ongoing credit exposure through the active review of customer balances against contract terms and due dates, including timely account reconciliation, dispute resolution and payment confirmation. The Company may employ collection agencies and legal counsel to pursue the recovery of defaulted receivables.

10

At June 30, 2025 and 2024, the Company reported $848 million and $725 million of accounts receivable, respectively, net of allowances of $31 million and $30 million, respectively. Changes in the allowance were not material for each of the three and six months ended June 30, 2025 and 2024.

4. Inventories

Major classes of inventory at June 30, 2025, December 31, 2024 and June 30, 2024 are as follows:

June 30,

December 31,

June 30,

    

2025

    

2024

    

2024

Finished goods

$

742

$

745

$

957

Raw materials

 

196

 

169

 

144

Operating supplies

 

52

 

49

 

52

$

990

$

963

$

1,153

5. Derivative Instruments

The Company has certain derivative assets and liabilities, which consist of natural gas forwards and collars, foreign exchange option and forward contracts, interest rate swaps and cross-currency swaps. The valuation of these instruments is determined primarily using the income approach, including discounted cash flow analysis on the expected cash flows of each derivative. Natural gas prices, foreign exchange rates and interest rates are the significant inputs into the valuation models. The Company also evaluates counterparty risk in determining fair values. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. Estimates of the fair value of foreign currency and commodity derivative instruments are determined using exchange traded prices and rates. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. These inputs are observable in active markets over the terms of the instruments the Company holds, and, accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy.

Commodity Forward Contracts and Collars Designated as Cash Flow Hedges

The Company has entered into commodity forward contracts and collars related to forecasted natural gas requirements, the objective of which are to limit the effects of fluctuations in future market prices of natural gas and the related volatility in cash flows.

An unrecognized gain of $1 million at June 30, 2025 and unrecognized losses of $2 million and $3 million at December 31, 2024 and June 30, 2024, respectively, related to the commodity forward contracts and collars was included in Accumulated other comprehensive income (loss) (“Accumulated OCI”), and will be reclassified into earnings over the next 12 months.

Cash Flow Hedges of Foreign Exchange Risk

The Company has variable-interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency.  The Company uses derivatives to manage these exposures and designates these derivatives as cash flow hedges of foreign currency exchange risk.

No unrecognized gains related to cross-currency swaps were included in Accumulated OCI at June 30, 2025, December 31, 2024 and June 30, 2024.

11

Fair Value Hedges of Foreign Exchange Risk

The Company has fixed and variable interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency.  The Company uses derivatives to manage these exposures and designates these derivatives as fair value hedges of foreign currency exchange risk. Approximately $2 million, $12 million and $3 million of the components were excluded from the assessment of effectiveness and are included in Accumulated OCI at June 30, 2025, December 31, 2024 and June 30, 2024, respectively.

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in non-U.S. subsidiaries and uses cross-currency swaps to partially hedge this exposure.

Foreign Exchange Derivative Contracts Not Designated as Hedging Instruments

The Company uses short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company also uses foreign exchange agreements to offset the foreign currency exchange rate risk for receivables and payables, including intercompany receivables, payables, and loans, not denominated in, or indexed to, their functional currencies.

Balance Sheet Classification

The following table shows the amount and classification (as noted above) of the Company’s derivatives at June 30, 2025, December 31, 2024 and June 30, 2024:

Fair Value of

Fair Value of

Hedge Assets

Hedge Liabilities

June 30,

December 31,

June 30,

June 30,

December 31,

June 30,

    

2025

    

2024

    

2024

    

2025

    

2024

    

2024

Derivatives designated as hedging instruments:

    

    

    

    

    

    

Commodity forward contracts and collars (a)

$

$

$

$

1

$

6

$

10

Fair value hedges of foreign exchange risk (b)

1

8

6

163

69

82

Net investment hedges (c)

9

7

3

142

29

37

Total derivatives accounted for as hedges

$

10

$

15

$

9

$

306

$

104

$

129

Derivatives not designated as hedges:

Foreign exchange derivative contracts (d)

14

2

2

1

10

8

Total derivatives

$

24

$

17

$

11

$

307

$

114

$

137

Current

$

24

$

17

$

11

$

157

$

12

$

12

Noncurrent

150

102

125

Total derivatives

$

24

$

17

$

11

$

307

$

114

$

137

(a)The notional amount of the commodity forward contracts and collars was approximately 9 million, 28 million, and 33 million British Thermal Units at June 30, 2025, December 31, 2024, and June 30, 2024, respectively. The maximum maturity dates are in 2027 at June 30, 2025, December 31, 2024, and June 30, 2024.

12

(b)The notional amounts of the fair value hedges of foreign exchange risk were $816 million at June 30, 2025, $816 million at December 31, 2024 and $833 million at June 30, 2024. The maximum maturity dates are in 2030 at June 30, 2025, December 31, 2024 and June 30, 2024.
(c)The notional amounts of the net investment hedges were 844 million at June 30, 2025, 483 million at December 31, 2024 and 483 million at June 30, 2024. The maximum maturity dates are in 2028 at June 30, 2025 and in 2026 at December 31, 2024 and June 30, 2024.
(d)The notional amounts of the foreign exchange derivative contracts were $506 million, $680 million and $572 million at June 30, 2025, December 31, 2024 and June 30, 2024, respectively. The maximum maturity dates are in 2025 at June 30, 2025, and in 2025 at December 31, 2024 and June 30, 2024.

Gain (Loss) Recognized in OCI (Effective Portion)

Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1)

Three months ended June 30,

Three months ended June 30,

Derivatives designated as hedging instruments:

 

2025

2024

2025

2024

Cash Flow Hedges

    

    

    

    

    

    

Commodity forward contracts and collars (a)

$

(1)

$

$

$

(3)

Net Investment Hedges

Net Investment Hedges (b)

(74)

6

3

1

$

(75)

$

6

$

3

$

(2)

Gain (Loss) Recognized in OCI (Effective Portion)

Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1)

Six months ended June 30,

Six months ended June 30,

Derivatives designated as hedging instruments:

 

2025

2024

2025

2024

Cash Flow Hedges

    

    

    

    

    

    

Commodity forward contracts and collars (a)

$

5

$

(4)

$

$

(6)

Net Investment Hedges

Net Investment Hedges (b)

(111)

21

6

3

$

(106)

$

17

$

6

$

(3)

Amount of Gain (Loss) Recognized in Other expense, net

Amount of Gain (Loss) Recognized in Other expense, net

Three months ended June 30,

Six months ended June 30,

Derivatives not designated as hedges:

 

2025

2024

2025

2024

Foreign exchange derivative contracts

    

$

19

    

$

(12)

    

$

25

$

(15)

(1) Gains and losses reclassified from Accumulated OCI and recognized in income are recorded to (a) cost of goods sold or (b) interest expense, net.

13

6. Restructuring Accruals

Selected information related to the restructuring accruals for the three months ended June 30, 2025 and 2024 is as follows:

Selected information related to the restructuring accruals for the three months ended June 30, 2025 and 2024 is as follows:

Fit to Win program

Other Restructuring

Employee

Asset

Other

Employee

Asset

Other

Total

    

Costs

Impairment

Exit Costs

    

Costs

Impairment

Exit Costs

Restructuring

Balance at April 1, 2025

$

78

$

$

32

$

6

$

$

4

$

120

Charges

8

104

1

113

Write-down of assets to net realizable value

(104)

(104)

Net cash paid, principally severance and related benefits

 

(46)

(2)

 

(1)

(1)

 

(50)

Other, including foreign exchange translation

 

7

 

 

7

Balance at June 30, 2025

$

47

$

$

31

$

5

$

$

3

$

86

Other Restructuring

Employee

Asset

Other

Total

Costs

Impairment

Exit Costs

Restructuring

Balance at April 1, 2024

$

19

$

$

10

$

29

Net cash paid, principally severance and related benefits

 

(4)

(1)

 

(5)

Balance at June 30, 2024

$

15

$

$

9

$

24

Selected information related to the restructuring accruals for the six months ended June 30, 2025 and 2024 is as follows:

Selected information related to the restructuring accruals for the six months ended June 30, 2025 and 2024 is as follows:

Fit to Win program

Other Restructuring

Employee

Asset

Other

Employee

Asset

Other

Total

Costs

Impairment

Exit Costs

Costs

Impairment

Exit Costs

Restructuring

Balance at January 1, 2025

$

51

$

$

18

$

7

$

$

4

$

80

Charges

58

118

19

195

Write-down of assets to net realizable value

(118)

(118)

Net cash paid, principally severance and related benefits

 

(69)

(6)

 

(2)

(1)

 

(78)

Other, including foreign exchange translation

 

7

 

 

7

Balance at June 30, 2025

$

47

$

$

31

$

5

$

$

3

$

86

14

Other Restructuring

Employee

Asset

Other

Total

Costs

Impairment

Exit Costs

Restructuring

Balance at January 1, 2024

$

27

$

$

12

$

39

Net cash paid, principally severance and related benefits

 

(12)

(3)

(15)

Balance at June 30, 2024

$

15

$

$

9

$

24

When a decision is made to take restructuring actions, the Company manages and accounts for them programmatically apart from the ongoing operations of the business. Information related to major programs is presented separately, while minor initiatives are presented on a combined basis.

As of June 30, 2025, the Company’s only major restructuring program was the Fit to Win initiative, which is expected to reduce redundant production capacity and begin to optimize the network, as well as streamline other cost areas, such as selling, general and administrative expenses.  The Fit to Win initiative began in the second half of 2024 and is expected to last at least through 2026. Details regarding charges, payments and other changes to the Fit to Win restructuring accruals are presented in the table above. Management does not yet have an estimate for the total restructuring charges to be incurred with this program, however, the total charges are expected to be material. As of June 30, 2024, no major restructuring programs were in effect.

For the three and six months ended June 30, 2025, the Company recorded restructuring, asset impairment and other charges of approximately $113 million (which included $104 million related to its decision to halt the MAGMA program) and $195 million, respectively, to Other expense, net in the Condensed Consolidated Results of Operations, of which all related to the Fit to Win program. For the three months ended June 30, 2025, these charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($50 million), Europe segment ($3 million) and Retained corporate costs and other ($60 million). For the six months ended June 30, 2025, these charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($56 million), Europe segment ($55 million) and Retained corporate costs and other ($84 million). As of June 30, 2025, the Company has incurred cumulative charges of approximately $396 million related to the Fit to Win program. Additional restructuring charges are expected in future quarters when management completes their assessment to reduce redundant production capacity and streamline costs. The Company expects that the majority of the remaining cash expenditures related to the accrued employee and other exit costs will be paid out over the next several years.

The Company’s decisions to curtail selected production capacity have resulted in write-downs of certain long-lived assets to the extent their carrying value exceeded fair value or fair value less cost to sell. The Company classified the assumptions used to determine the fair value of the impaired assets in the period that the measurement was taken as Level 3 (third-party appraisals, where applicable) in the fair value hierarchy as set forth in the general accounting principles for fair value measurements. For the asset impairments recorded during the three and six months ended June 30, 2025, the remaining carrying value of the impaired assets was approximately $0.

15

7. Pension Benefit Plans

The components of the net periodic pension cost for the three months ended June 30, 2025 and 2024 are as follows:

U.S.

Non-U.S.

 

Three months ended June 30,

Three months ended June 30,

    

2025

    

2024

    

2025

    

2024

 

Service cost

$

1

$

1

$

2

$

2

Interest cost

 

11

 

11

 

9

 

9

Expected asset return

(12)

(13)

(8)

(8)

Amortization of actuarial loss

3

3

2

3

Net periodic pension cost

$

3

$

2

$

5

$

6

The components of the net periodic pension cost for the six months ended June 30, 2025 and 2024 are as follows:

U.S.

Non-U.S.

 

Six months ended June 30,

Six months ended June 30,

    

2025

    

2024

    

2025

    

2024

 

Service cost

$

2

$

2

$

4

$

4

Interest cost

 

22

 

22

 

17

 

18

Expected asset return

(25)

(26)

(15)

(16)

Amortization of actuarial loss

6

6

4

6

Net periodic pension cost

$

5

$

4

$

10

$

12

The components of pension expense, other than the service cost component, are included in Other expense, net in the Condensed Consolidated Results of Operations.

8. Income Taxes

The Company calculates its interim tax provision using the estimated annual effective tax rate (“EAETR”) methodology in accordance with ASC 740-270. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision. The determination of the EAETR is based upon a number of estimates, including the estimated annual pretax ordinary income or loss in each tax jurisdiction in which the Company operates. The tax effects of discrete items are recognized in the tax provision in the quarter they occur, in accordance with U.S. GAAP. Depending on various factors, such as the item’s significance in relation to total income and the rate of tax applicable in the jurisdiction to which it relates, discrete items in any quarter can materially impact the reported effective tax rate. The Company’s annual effective tax rate may be affected by the mix of earnings in the U.S. and foreign jurisdictions, and factors such as changes in tax laws, tax rates or regulations, changes in business, changing interpretation of existing tax laws or regulations and the finalization of tax audits and reviews, as well as other factors. As such, there can be significant volatility in interim tax provisions. The annual effective tax rate differs from the statutory U.S. Federal tax rate of 21%, primarily because of varying non-U.S. tax rates and the impact of the U.S. valuation allowance.

The Company is currently under income tax examination in various tax jurisdictions in which it operates, including Brazil, Canada, Colombia, Germany, Indonesia, Italy, Peru, and the U.S. The years under examination range from 2004 through 2023. The Company has received tax assessments in excess of established reserves. The Company is contesting these tax assessments, and will continue to do so, including pursuing all available remedies, such as appeals and litigation, if necessary. The Company believes that adequate provisions for all income tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact on the Company’s consolidated results of operations, financial position or cash flows. Due to uncertainties regarding the ultimate resolution of income tax examinations, the Company is not able to reasonably estimate any tax assessments that may be settled at amounts in excess of established reserves in future periods, or the future periods in which any income tax payments to settle these provisions for income tax uncertainties.

16

On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA”) was enacted into law in the U.S. The OBBBA includes the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business deductions. The legislation has multiple effective dates, with certain provisions effective in 2025. The Company is currently assessing its impact on its consolidated financial statements.

9. Debt

The following table summarizes the long-term debt of the Company at June 30, 2025, December 31, 2024, and June 30, 2024:

June 30,

December 31,

June 30,

    

2025

    

2024

    

2024

Secured Credit Agreement:

Revolving Credit Facility:

Revolving Loans

$

205

$

$

Term Loans:

Term Loan A

1,339

1,338

1,392

Senior Notes:

3.125%, due 2024 (€58 million at June 30, 2024)

62

5.375%, due 2025

17

17

2.875%, due 2025 (€176 million at December 31, 2024 and June 30, 2024)

183

188

6.625%, due 2027

610

609

609

6.250%, due 2028 (€600 million)

699

619

635

5.250%, due 2029 (€500 million)

580

514

527

4.750%, due 2030

397

397

397

7.250%, due 2031

683

683

682

7.375%, due 2032

296

296

296

Finance leases

186

195

189

Other

 

8

8

1

Total long-term debt

 

5,003

 

4,859

4,995

Less amounts due within one year

 

105

306

347

Long-term debt

$

4,898

$

4,553

$

4,648

The Company presents debt issuance costs in the Condensed Consolidated Balance Sheets as a deduction of the carrying amount of the related debt liability.

On March 25, 2022, certain of the Company’s subsidiaries entered into a Credit Agreement and Syndicated Facility Agreement (the “Original Agreement”), which refinanced in full the previous credit agreement. The Original Agreement provided for up to $2.8 billion of borrowings pursuant to term loans, revolving credit facilities and a delayed draw term loan facility. The delayed draw term loan facility allowed for a one-time borrowing of up to $600 million, the proceeds of which were used, in addition to other consideration paid by the Company and/or its subsidiaries, to fund an asbestos settlement trust (the “Paddock Trust”) established in connection with the confirmed plan of reorganization of Paddock Enterprises, LLC (“Paddock”) proposed by Paddock, O-I Glass and certain other parties in Paddock’s Chapter 11 case. On July 18, 2022, the Company drew down the $600 million delayed draw term loan to fund, together with other consideration, the Paddock Trust.

On August 30, 2022, certain of the Company’s subsidiaries entered into an Amendment No. 1 to its Credit Agreement and Syndicated Facility Agreement (the “Credit Agreement Amendment”), which amends the Original Agreement (as amended by the Credit Agreement Amendment, the “Credit Agreement”). The Credit Agreement Amendment provides for up to $500 million of additional borrowings in the form of term loans. The proceeds of such term loans were used, together with cash, to retire the $600 million delayed draw term loan. The term loans mature, and the revolving credit facilities terminate, in March 2027. The term loans borrowed under the Credit Agreement

17

Amendment are secured by certain collateral of the Company and certain of its subsidiaries. In addition, the Credit Agreement Amendment makes modifications to certain loan documents, in order to give the Company increased flexibility to incur secured debt in the future.

At June 30, 2025, the Credit Agreement includes a $300 million revolving credit facility, a $950 million multicurrency revolving credit facility and $1.45 billion in term loan A facilities ($1.34 billion outstanding balance at June 30, 2025, net of debt issuance costs). At June 30, 2025, the Company had unused credit of $1.04 billion available under the revolving credit facilities as part of the Credit Agreement. The weighted average interest rate on borrowings outstanding under the Credit Agreement at June 30, 2025 was 6.08%.

The Credit Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain indebtedness and liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations.

The Credit Agreement also contains one financial maintenance covenant, a Secured Leverage Ratio (as defined in the Credit Agreement), that requires the Company not to exceed a ratio of 2.50x calculated by dividing consolidated Net Indebtedness that is then secured by Liens on property or assets of the Company and certain of its subsidiaries by Consolidated EBITDA, as each term is defined and as described in the Credit Agreement. The Secured Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Secured Leverage Ratio to exceed the specified maximum.

Failure to comply with these covenants and restrictions could result in an event of default under the Credit Agreement. In such an event, the Company could not request additional borrowings under the revolving facilities, and all amounts outstanding under the Credit Agreement, together with accrued interest, could then be declared immediately due and payable. Upon the occurrence and for the duration of a payment event of default, an additional default interest rate equal to 2.0% per annum will apply to all overdue obligations under the Credit Agreement. If an event of default occurs under the Credit Agreement and the lenders cause all of the outstanding debt obligations under the Credit Agreement to become due and payable, this would result in a default under the indentures governing the Company’s outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of June 30, 2025, the Company was in compliance with all covenants and restrictions in the Credit Agreement.  In addition, the Company believes that it will remain in compliance for the term of the Credit Agreement and that its ability to borrow additional funds under the Credit Agreement will not be adversely affected by the covenants and restrictions.

The Total Leverage Ratio (as defined in the Credit Agreement) determines pricing under the Credit Agreement. The interest rate on borrowings under the Credit Agreement is, at the Company’s option, the Base Rate, Term SOFR or, for non-U.S. dollar borrowings only, the Eurocurrency Rate (each as defined in the Credit Agreement), plus an applicable margin. The applicable margin is linked to the Total Leverage Ratio. The margins range from 1.00% to 2.25% for Term SOFR loans and Eurocurrency Rate loans and from 0.00% to 1.25% for Base Rate loans. In addition, a commitment fee is payable on the unused revolving credit facility commitments ranging from 0.20% to 0.35% per annum linked to the Total Leverage Ratio.

Obligations under the Credit Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Such obligations are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign obligations, of stock of certain foreign subsidiaries. All obligations under the Credit Agreement are guaranteed by certain domestic subsidiaries of the Company, and certain foreign obligations under the Credit Agreement are guaranteed by certain foreign subsidiaries of the Company.

In May 2024, the Company issued 500 million aggregate principal amount of senior notes that bear interest at 5.250% and mature on June 1, 2029. Also, in May 2024, the Company issued $300 million aggregate principal amount of senior notes that bear interest at 7.375% and mature on June 1, 2032. The senior notes were issued via private placements and are guaranteed by certain of the Company’s subsidiaries. The net proceeds, after deducting debt issuance

18

costs, were used to repurchase and redeem the aggregate principal amounts described in the May 2024 tender offer and redemption below.

In May 2024, the Company repurchased 323.4 million aggregate principal amount of the outstanding 2.875% Senior Notes due 2025 pursuant to a tender offer and redeemed $300 million aggregate principal amount of the outstanding 6.375% Senior Notes due 2025. The repurchase and redemption were funded with the proceeds from the May 2024 senior notes issuances described above. The Company recorded approximately $2 million of additional interest charges related to the senior note repurchases conducted in the second quarter of 2024 for note repurchase premiums and the write-off of unamortized finance fees. In the first quarter of 2025, the 2.875% Senior Notes due 2025 were fully repaid.  

The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market.

The carrying amounts reported for certain long-term debt obligations subject to frequently redetermined interest rates approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations and are classified as Level 1 in the fair value hierarchy. Fair values at June 30, 2025 of the Company’s significant fixed rate debt obligations are as follows:

Principal

Indicated Market

    

Amount

    

Price

    

Fair Value

Senior Notes:

6.625%, due 2027

$

612

100.26

$

614

6.250%, due 2028 (€600 million)

704

103.40

728

5.250%, due 2029 (€500 million)

587

103.06

605

4.750%, due 2030

400

96.09

384

7.250%, due 2031

690

102.68

708

7.375%, due 2032

300

102.19

307

10. Contingencies

The Company has been identified by the U.S. Environmental Protection Agency or a comparable state or federal agency as a potentially responsible party (“PRP”) at a number of sites in the U.S., including certain Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (“CERCLA”) (Superfund) sites, as well as sites previously owned or operated by the Company.  As an identified PRP, the Company may have liability for investigation, remediation and monitoring of contamination, as well as associated penalties and natural resource damages, if any.  The Company has not had monetary sanctions imposed nor has the Company been notified of any potential monetary sanctions at any of the sites.  

The Company has recorded aggregate accruals of approximately $38 million, $35 million and $33 million (undiscounted) as of June 30, 2025, December 31, 2024 and June 30, 2024, respectively, for estimated future remediation and monitoring costs at these sites. Although the Company believes its accruals are adequate to cover its portion of future remediation and monitoring costs, there can be no assurance that the ultimate payments will not exceed the amount of the Company’s accruals and will not have a material effect on its results of operations, financial position and cash flows.  Other than related to the site discussed below, any possible loss or range of potential loss that may be incurred in excess of the recorded accruals cannot be estimated.

As part of the above, from December 31, 1956 through June 1967, the Company, via a wholly-owned subsidiary, owned and operated a paper mill located on the shore of the Cuyahoga River in Ohio, which is now part of the Cuyahoga Valley National Park that is managed by the National Park Service (“NPS”).  The Company and the United States have been engaged in litigation regarding the site in the U.S. District Court for the Northern District of Ohio (Akron), with the

19

United States claiming that the Company should pay $50 million as a remedy for certain soils at the site as well as its past and anticipated future costs. In the first quarter of 2025, the Company and the NPS reached a tentative settlement, and the Company expects to pay $16.5 million in the third quarter of 2025 to resolve this matter. As a result, the Company recorded a charge of approximately $4 million in the first quarter of 2025 to Other expense, net in the Condensed Consolidated Results of Operations to augment its previous accrual balance related to this matter.  The consent order between the parties was approved by the U.S. District Court in July 2025.

In November 2023, the Autorita Garante della Concorrenza e del Mercato (the “Italian Competition Authority”) commenced an investigation into alleged anti-competitive conduct by nine glass manufacturers and distributors in Italy, including the Company’s subsidiary based in Italy, O-I Italy SpA (“O-I Italy”), and an Italian joint venture in which O-I Italy owns a 50% interest, related to the sale of wine bottles in Italy. The Italian Competition Authority’s investigation is ongoing. To date, the Italian Competition Authority has not officially charged O-I Italy or its joint venture with any violations of competition law. If the Italian Competition Authority finds that the Company or any of its subsidiaries or joint ventures violated competition law, the Italian Competition Authority could levy fines, which could be material. At this stage, the Company is unable to predict the ultimate outcome of the investigation and any potential loss cannot be estimated. 

Similar to the Italian anti-competitive investigation discussed above, the Company is also being investigated by authorities in France and Ecuador for similar conduct in those countries. To date, neither the French nor Ecuadorian authorities have officially charged O-I’s businesses in those countries with any violations of competition law. With regard to the above, the Company is committed to compliance with laws in the jurisdictions it operates and maintains policies and procedures regarding competition law.  If the authorities in these countries find that the Company or any of its subsidiaries or joint ventures violated competition law, they could levy fines, which amounts could be material. At this stage, the Company is unable to predict the ultimate outcome of the investigations, and any potential loss cannot be estimated. 

Other litigation is pending against the Company, in some cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events.

20

11. Share Owners’ Equity

The activity in share owners’ equity for the three months ended June 30, 2025 and 2024 is as follows:

Share Owners’ Equity of the Company

    

    

    

    

    

Accumulated

    

    

 

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

Stock

Par Value

Stock

Earnings

Loss

Interests

Equity

Balance on April 1, 2025

$

2

$

3,045

(679)

$

660

$

(1,914)

$

135

$

1,249

Reissuance of common stock (0.2 million shares)

(2)

5

 

3

Shares repurchased (0.9 million shares)

(10)

 

(10)

Stock compensation (0.1 million shares)

4

 

4

Net earnings (loss)

(5)

6

 

1

Other comprehensive income

129

 

129

Distributions to non-controlling interests

(8)

(8)

Balance on June 30, 2025

$

2

$

3,037

$

(674)

$

656

$

(1,785)

$

133

$

1,369

Share Owners’ Equity of the Company

    

    

    

    

    

Accumulated

    

    

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

    

Stock

    

Par Value

    

Stock

Earnings

Loss

Interests

Equity

 

Balance on April 1, 2024

$

2

$

3,081

$

(690)

$

854

$

(1,560)

$

139

$

1,826

Reissuance of common stock (0.2 million shares)

(1)

5

 

4

Shares repurchased (0.6 million shares)

(10)

(10)

Stock compensation (1.9 million shares)

(1)

 

(1)

Net earnings

57

5

 

62

Other comprehensive loss

(234)

(7)

 

(241)

Other

(9)

(9)

Balance on June 30, 2024

$

2

$

3,069

$

(685)

$

911

$

(1,794)

$

128

$

1,631

21

The activity in share owners’ equity for the six months ended June 30, 2025 and 2024 is as follows:

Share Owners’ Equity of the Company

    

    

    

    

    

Accumulated

    

    

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

Stock

Par Value

Stock

Earnings

Loss

Interests

Equity

 

Balance on January 1, 2025

$

2

$

3,053

$

(677)

$

676

$

(1,975)

$

126

$

1,205

Reissuance of common stock (0.4 million shares)

(4)

10

6

Shares repurchased (1.9 million shares)

(20)

(20)

Stock compensation (1.4 million shares)

8

8

Net earnings (loss)

(20)

10

(10)

Other comprehensive income

190

5

195

Distributions to non-controlling interests

(8)

(8)

Other

(7)

(7)

Balance on June 30, 2025

$

2

$

3,037

$

(674)

$

656

$

(1,785)

$

133

$

1,369

Share Owners’ Equity of the Company

    

    

    

    

    

Accumulated

    

    

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

Stock

Par Value

Stock

Earnings

Loss

Interests

Equity

 

Balance on January 1, 2024

$

2

$

3,086

$

(681)

$

782

$

(1,580)

$

135

$

1,744

Reissuance of common stock (0.4 million shares)

(3)

10

 

7

Shares repurchased (1.3 million shares)

(20)

(20)

Stock compensation (1.9 million shares)

6

 

6

Net earnings

129

9

 

138

Other comprehensive loss

(214)

(7)

 

(221)

Distributions to non-controlling interests

(9)

(9)

Other

(14)

(14)

Balance on June 30, 2024

$

2

$

3,069

$

(685)

$

911

$

(1,794)

$

128

$

1,631

During the three months ended June 30, 2025, the Company purchased 938,029 shares of its common stock for approximately $10 million. The share purchases were made pursuant to a $100 million anti-dilutive share repurchase program authorized by the Company’s Board of Directors on May 14, 2024, which is intended to offset stock-based compensation provided to the Company’s directors, officers, and employees. Approximately $60 million remained available for purchases under this program as of June 30, 2025.

22

The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows:

Shares Outstanding (in thousands)

 

June 30,

December 31,

June 30,

 

    

2025

    

2024

    

2024

 

Shares of common stock issued (including treasury shares)

 

184,985

184,851

187,083

Treasury shares

 

30,912

30,784

31,361



12. Accumulated Other Comprehensive Loss

The activity in accumulated other comprehensive loss for the three months ended June 30, 2025 and 2024 is as follows:

Total

 

Accumulated

Net Effect of

Change in Certain

Other

Exchange Rate

Derivative

Employee

Comprehensive

 

    

Fluctuations

    

Instruments

    

Benefit Plans

    

Loss

 

Balance on April 1, 2025

$

(1,343)

$

(42)

$

(529)

$

(1,914)

Change before reclassifications

 

213

(83)

1

 

131

Amounts reclassified from accumulated other comprehensive income (loss)

3

(a)  

 

5

(b)  

 

8

Translation effect

(12)

(12)

Tax effect

3

(1)

2

Other comprehensive loss attributable to the Company

 

213

 

(77)

 

(7)

 

129

Balance on June 30, 2025

$

(1,130)

$

(119)

$

(536)

$

(1,785)

Total

Accumulated

 

Net Effect of

Change in Certain

Other

Exchange Rate

Derivative

Employee

Comprehensive

    

Fluctuations

    

Instruments

    

Benefit Plans

    

Loss

 

Balance on April 1, 2024

$

(944)

$

(34)

$

(582)

$

(1,560)

 

Change before reclassifications

 

(250)

14

 

(236)

Amounts reclassified from accumulated other comprehensive income (loss)

(2)

(a)  

 

6

(b)  

 

4

Translation effect

(1)

1

Tax effect

(1)

(1)

(2)

Other comprehensive income (loss) attributable to the Company

 

(250)

 

10

 

6

 

(234)

Balance on June 30, 2024

$

(1,194)

$

(24)

$

(576)

$

(1,794)

(a)Amount is recorded to cost of goods sold and interest expense, net in the Condensed Consolidated Results of Operations (see Note 5 for additional information).
(b)Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net post-retirement benefit cost.

23

The activity in accumulated other comprehensive loss for the six months ended June 30, 2025 and 2024 is as follows:

Total

Accumulated

 

Net Effect of

Change in Certain

Other

Exchange Rate

Derivative

Employee

Comprehensive

   

Fluctuations

   

Instruments

   

Benefit Plans

   

Loss

 

Balance on January 1, 2025

$

(1,435)

$

(14)

$

(526)

$

(1,975)

   

Change before reclassifications

 

305

(111)

(1)

 

193

Amounts reclassified from accumulated other comprehensive income (loss)

6

(a)  

 

10

(b)  

 

16

Translation effect

(18)

(18)

Tax effect

 

(1)

 

(1)

Other comprehensive income (loss) attributable to the Company

 

305

 

(105)

 

(10)

 

190

Balance on June 30, 2025

$

(1,130)

$

(119)

$

(536)

$

(1,785)

Total

Accumulated

 

Net Effect of

Change in Certain

Other

Exchange Rate

Derivative

Employee

Comprehensive

   

Fluctuations

   

Instruments

   

Benefit Plans

   

Loss

 

Balance on January 1, 2024

$

(949)

$

(43)

$

(588)

$

(1,580)

   

Change before reclassifications

 

(245)

22

(1)

 

(224)

Amounts reclassified from accumulated other comprehensive income (loss)

(3)

(a)  

 

12

(b)  

 

9

Translation effect

2

2

Tax effect

 

(1)

 

(1)

Other comprehensive income (loss) attributable to the Company

 

(245)

 

19

 

12

 

(214)

Balance on June 30, 2024

$

(1,194)

$

(24)

$

(576)

$

(1,794)

(a)Amount is recorded to cost of goods sold and interest expense, net in the Condensed Consolidated Results of Operations (see Note 5 for additional information).
(b)Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net post-retirement benefit cost.

24

13. Other Expense, Net

Other expense, net for the three and six months ended June 30, 2025 and 2024 included the following:

Three months ended June 30,

Six months ended June 30,

    

2025

    

2024

    

2025

    

2024

Restructuring, asset impairment and other charges

$

(108)

$

$

(191)

$

Legacy environmental charge (see Note 10)

(10)

(4)

(10)

Gain on sale of miscellaneous assets

6

Intangible amortization expense

(7)

(7)

(13)

(15)

Foreign currency exchange loss

(3)

(3)

(3)

Royalty income

5

6

10

12

Other income (expense)

(5)

(1)

(5)

1

Other expense, net

$

(118)

$

(12)

$

(200)

$

(15)

14. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share for the three months ended June 30, 2025 and 2024:

Three months ended June 30,

    

2025

    

2024

Numerator:

 

    

 

    

Net earnings (loss) attributable to the Company

$

(5)

$

57

Denominator (in thousands):

Denominator for basic earnings per share-weighted average shares outstanding

 

153,993

155,280

Effect of dilutive securities:

Stock options and other

 

 

2,102

Denominator for diluted earnings per share-adjusted weighted average shares outstanding

 

153,993

157,382

Basic earnings per share:

Net earnings (loss) attributable to the Company

$

(0.03)

$

0.37

Diluted earnings per share:

Net earnings (loss) attributable to the Company

$

(0.03)

$

0.36

The diluted earnings (loss) per share computation for the three months ended June 30, 2025 and 2024 excludes 371,732 and 1,422,689 weighted average shares of common stock, respectively, due to their antidilutive effect, which includes unvested restricted stock units and performance vested restricted share units. For the three months ended June 30, 2025, diluted loss per share of common stock was equal to basic loss per share of common stock due to the net loss attributable to the Company.

25

The following table sets forth the computation of basic and diluted earnings per share for the six months ended June 30, 2025 and 2024:

Six months ended June 30,

    

2025

    

2024

Numerator:

 

 

    

Net earnings (loss) attributable to the Company

$

(20)

$

129

Denominator (in thousands):

Denominator for basic earnings per share-weighted average shares outstanding

 

153,851

 

154,777

Effect of dilutive securities:

Stock options and other

 

 

3,148

Denominator for diluted earnings per share-adjusted weighted average shares outstanding

 

153,851

 

157,925

Basic earnings per share:

Net earnings (loss) attributable to the Company

$

(0.13)

$

0.83

Diluted earnings per share:

Net earnings (loss) attributable to the Company

$

(0.13)

$

0.81

The diluted earnings (loss) per share computation for the six months ended June 30, 2025 and 2024 excludes 537,764 and 1,021,851 weighted average shares of common stock, respectively, due to their antidilutive effect, which includes unvested restricted stock units and performance vested restricted share units. For the six months ended June 30, 2025, diluted loss per share of common stock was equal to basic loss per share of common stock due to the net loss attributable to the Company.

15. Supplemental Cash Flow Information

Income taxes paid in cash were as follows:

Six months ended June 30,

    

2025

    

2024

 

U.S.

$

7

$

5

Non-U.S.

 

43

 

94

Total income taxes paid in cash

$

50

$

99

Interest paid in cash for the six months ended June 30, 2025 and 2024 was $178 million and $188 million, respectively.

The Company uses various factoring programs to sell certain trade receivables to financial institutions as part of managing its cash flows. Sales of trade receivables are accounted for in accordance with ASC Topic 860, Transfers and Servicing.  Trade receivables sold under the factoring programs are transferred without recourse to the Company and accounted for as true sales and, therefore, are excluded from Trade receivables, net in the Condensed Consolidated Balance Sheets. At June 30, 2025, December 31, 2024 and June 30, 2024, the total amount of trade receivables sold by the Company was $544 million, $535 million, and $632 million, respectively. These amounts included $201 million, $155 million and $252 million at June 30, 2025, December 31, 2024, and June 30, 2024, respectively, for trade receivable amounts factored under supply-chain financing programs linked to commercial arrangements with key customers. The Company is the master servicer for the factoring programs that are not associated with key customers and is responsible for administering and collecting receivables.

The Company’s use of its accounts receivable factoring programs resulted in an increase to cash provided by operating activities of approximately $9 million and $90 million for the six months ended June 30, 2025 and June 30,

26

2024, respectively. For the six months ended June 30, 2025 and 2024, the Company recorded expenses related to these factoring programs of approximately $9 million and $13 million, respectively.

In accordance with ASU 2022-04, “Liabilities-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations,” the Company has agreements with third-party administrators that allow participating vendors to track the Company’s payments and, if voluntarily elected by the vendor, to sell payment obligations from the Company to financial institutions as part of a Supply Chain Financing (“SCF”) Program.  The Company's payment terms to the financial institutions, including the timing and amount of payments, are based on the original supplier invoices. When participating vendors elect to sell one or more of the Company’s payment obligations, the Company’s rights and obligations to settle the payables on their contractual due date are not impacted. The Company has no economic or commercial interest in a vendor’s decision to enter into these agreements, and the financial institutions do not provide the Company with incentives, such as rebates or profit sharing under the SCF Program. The Company agrees on commercial terms with vendors for the goods and services procured, which are consistent with payment terms observed at other peer companies in the industry, and the terms are not impacted by the SCF Program. Such obligations are classified as accounts payable in its Condensed Consolidated Balance Sheets. The Company does not provide asset pledges, or other forms of guarantees, as security for the committed payment to the financial institutions. As of June 30, 2025, December 31, 2024 and June 30, 2024, the Company had approximately $121 million, $82 million, and $91 million, respectively, of outstanding payment obligations to the financial institutions as part of the SCF Program.

The Company’s outstanding obligations under the SCF Program are as follows:

Three months ended June 30,

Six months ended June 30,

2025

    

2024

    

2025

    

2024

    

Confirmed obligations outstanding at the beginning of the period

$

68

$

94

$

82

$

114

Invoices confirmed during the period

 

89

 

101

 

167

 

201

Confirmed invoices paid during the period

(36)

(104)

(128)

(224)

Confirmed obligations outstanding at the end of the period

$

121

$

91

$

121

$

91

16. Subsequent Events

In late July 2025, the Company finalized its plans for the indefinite suspension of operations of one furnace and the closure of one plant in its Americas segment. These actions are part of the Company’s Fit to Win initiative to reduce redundant capacity and begin to optimize its network.  Additional furnace closures and other restructuring actions are expected later in 2025.  

These capacity closures in the Americas segment are expected to occur on or after August 1, 2025. Current customers of the plants impacted by the closures will be served by other Americas plants in the Company’s network. Subject to finalization of certain estimates, the Company expects to record charges associated with these closures of approximately $45 million in the third quarter of 2025.  Major components of the charges include approximately $35 million for impairment of plant-related assets, such as the closed furnaces and related machinery, and $10 million for one-time employee separation benefits and other costs related to the closures (of which approximately $10 million relates to future cash expenditures). 

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings before interest expense, net and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations and other adjustments, as well as certain retained corporate costs. The segment data presented below is prepared in accordance with general accounting principles for segment reporting. The lines titled “reportable segment totals” in both net sales and segment operating profit, however, are non-GAAP measures when presented outside of the financial statement footnotes. Management has included reportable segment totals below to facilitate the discussion and analysis of financial condition and results of operations and believes this information allows the Board of Directors, management, investors and analysts to better understand the Company’s financial performance. The Company’s management, including the chief operating decision maker (defined as the Chief Executive Officer), uses segment operating profit, supplemented by net sales and selected cash flow information, to evaluate segment performance and allocate resources. Segment operating profit is not, however, intended as an alternative measure of operating results as determined in accordance with U.S. GAAP and is not necessarily comparable to similarly titled measures used by other companies.

Financial information for the three and six months ended June 30, 2025 and 2024 regarding the Company’s reportable segments is as follows (dollars in millions):

Three months ended

Six months ended

June 30,

June 30,

    

2025

    

2024

    

2025

    

2024

    

Net Sales:

Americas

$

943

$

899

$

1,816

$

1,753

Europe

 

741

 

802

 

1,407

 

1,511

Reportable segment totals

 

1,684

 

1,701

 

3,223

 

3,264

Other

 

22

 

28

 

50

 

58

Net Sales

$

1,706

$

1,729

$

3,273

$

3,322

Three months ended

Six months ended

June 30,

June 30,

    

2025

    

2024

    

2025

    

2024

Net earnings (loss) attributable to the Company

$

(5)

$

57

$

(20)

$

129

Net earnings attributable to non-controlling interests

 

6

 

5

 

10

 

9

Net earnings (loss)

 

1

 

62

 

(10)

 

138

Provision for income taxes

6

42

36

83

Earnings before income taxes

 

7

 

104

 

26

221

Items excluded from segment operating profit:

Retained corporate costs and other

25

32

53

72

Restructuring, asset impairment and other charges

108

191

Legacy environmental charge

10

4

10

Gain on sale of miscellaneous assets

(6)

Interest expense, net

 

85

 

87

 

166

165

Segment operating profit

$

225

$

233

$

434

$

468

Americas

 

135

 

106

 

276

 

208

Europe

 

90

 

127

 

158

 

260

Reportable segment totals

$

225

$

233

$

434

$

468

Note: All amounts excluded from reportable segment totals are discussed in the following applicable sections.

28

Executive Overview — Quarters ended June 30, 2025 and 2024

Net sales in the second quarter of 2025 decreased $23 million, or 1%, compared to the prior year period, primarily due to lower average selling prices and sales volumes, partially offset by the impact from favorable foreign currency translation.

Earnings before income taxes were $97 million lower in the second quarter of 2025 compared to the same period in 2024. This decrease was primarily due to higher restructuring, asset impairment and other charges and lower segment operating profit, partially offset by lower interest expense and retained corporate and other costs.

Segment operating profit for reportable segments in the second quarter of 2025 was $8 million lower compared to the prior year period, primarily due to lower net prices (net of cost inflation) and sales volumes, partially offset by lower operating costs. Operating costs were favorably impacted by benefits from the Company’s Fit to Win initiative, partially offset by temporary curtailments of production volumes, primarily in Europe, to balance supply and demand and reduce inventory levels.

Net interest expense for the second quarter of 2025 decreased $2 million compared to the same period in 2024, primarily due to lower note repurchase premiums, write-offs of deferred finance fees and related charges.

For the second quarter of 2025, the Company recorded a net loss attributable to the Company of $5 million, or $0.03 per share, compared to net earnings attributable to the Company of $57 million, or $0.36 per share (diluted), in the second quarter of 2024. As discussed below, net loss attributable to the Company in the second quarter of 2025 and 2024 included items that management considers not representative of ongoing operations and other adjustments. These items increased net loss attributable to the Company by $86 million, or $0.56 per share, in the second quarter of 2025 and decreased net earnings attributable to the Company by $12 million, or $0.08 per share, in the second quarter of 2024.

Results of Operations — Second Quarter of 2025 Compared with Second Quarter of 2024

Net Sales

The Company’s net sales in the second quarter of 2025 were $1,706 million compared with $1,729 million in the second quarter of 2024, a decrease of $23 million, or 1%. Average selling prices declined, which decreased net sales by $19 million in the second quarter of 2025. Glass container shipments, in tons, decreased approximately 3% in the second quarter of 2025, which decreased net sales by approximately $26 million compared to the same period in the prior year. This decline in shipments was impacted by soft consumer consumption and generally unfavorable weather across much of the Northern Hemisphere. Favorable foreign currency exchange rates increased net sales by $28 million in the second quarter of 2025 compared to the same period in the prior year. Other sales were approximately $6 million lower in the second quarter of 2025 than in the same period in the prior year, driven by lower machine part sales and lower shipments in Asia Pacific.

The change in net sales of reportable segments can be summarized as follows (dollars in millions):

Reportable segment net sales - 2024

    

    

$

1,701

 

Price

$

(19)

Sales volume and mix

 

(26)

Effects of changing foreign currency rates

 

28

Total effect on reportable segment net sales

 

(17)

Reportable segment net sales - 2025

$

1,684

Americas: Net sales in the Americas in the second quarter of 2025 were $943 million compared to $899 million in the second quarter of 2024, an increase of $44 million, or 5%. Higher selling prices in the region increased net sales by $22 million in the second quarter of 2025, driven by the pass through of higher cost inflation. Glass container shipments in the region were up approximately 4% in the second quarter of 2025 compared to the same period in the prior year, which increased net sales by approximately $50 million. The segment experienced strong shipments to beer and spirits

29

customers. The unfavorable effects of foreign currency exchange rate changes decreased net sales by $28 million in the second quarter of 2025 compared to the same period in the prior year, as the Brazilian Real, Mexican Peso and Colombian Peso weakened compared to the U.S. dollar.

Europe: Net sales in Europe in the second quarter of 2025 were $741 million compared to $802 million in the second quarter of 2024, a decrease of $61 million, or 8%. Lower average selling prices in Europe decreased net sales by $41 million in the second quarter of 2025. Glass container shipments decreased by approximately 9% in the second quarter of 2025 with lower shipments to beer, wine and spirits customers, and this decreased net sales by approximately $76 million compared to the same period in the prior year. The Company believes that second quarter 2025 sales were adversely impacted by the following factors: a supplier-related delay at a major plant reconfiguration project which is now ramping up; some increased beer and wine shipments in the first quarter of 2025, likely in response to trade policy uncertainty; and macroeconomic uncertainty and unfavorable weather conditions. Favorable effects of foreign currency exchange rate changes increased net sales by $56 million in the second quarter of 2025 compared to the same period in the prior year, as the Euro strengthened compared to the U.S. dollar.

Earnings before Income Taxes and Segment Operating Profit

Earnings before income taxes were $7 million in the second quarter of 2025 compared to $104 million in the second quarter of 2024, a decrease of $97 million.  This decrease was due to higher restructuring, asset impairment and other charges and lower segment operating profit, partially offset by lower interest expense and retained corporate and other costs.

Segment operating profit of the reportable segments includes an allocation of some corporate expenses based on a percentage of sales and direct billings based on the costs of specific services provided. Unallocated corporate expenses and certain other expenses not directly related to the reportable segments’ operations are included in Retained corporate costs and other. For further information, see Segment Information included in Note 1 to the Condensed Consolidated Financial Statements.

Segment operating profit of reportable segments in the second quarter of 2025 was $225 million, compared to $233 million in the second quarter of 2024, a decrease of $8 million, or 3%. This decrease was primarily due to lower net prices (net of cost inflation) and sales volumes. Operating costs were favorably impacted by $63 million of benefits from the Company’s Fit to Win initiative, partially offset by approximately $32 million related to temporary curtailments of production volumes, primarily in Europe, to balance supply and demand and reduce inventory levels and other costs.

The change in segment operating profit of reportable segments can be summarized as follows (dollars in millions):

Reportable segment operating profit - 2024

    

    

$

233

 

Net price (net of cost inflation)

$

(31)

Sales volume and mix

(8)

Operating costs

 

31

Effects of changing foreign currency rates

Total net effect on reportable segment operating profit

(8)

Reportable segment operating profit - 2025

$

225

Americas: Segment operating profit in the Americas in the second quarter of 2025 was $135 million, compared to $106 million in the second quarter of 2024, an increase of $29 million, or 27%. The impact of higher shipments discussed above resulted in a $10 million increase to segment operating profit in the second quarter of 2025 compared to the second quarter of 2024. Higher cost inflation exceeded higher selling prices and resulted in a $7 million decrease to segment operating profit in the second quarter of 2025. The effects of foreign currency exchange rates decreased segment operating profit by $9 million in the second quarter of 2025.

In addition, operating costs in the second quarter of 2025 were $35 million lower than in the same period in the prior year, primarily due to approximately $29 million of benefits from the Company’s Fit To Win initiative (exceeding management’s expectations).

30

Europe: Segment operating profit in Europe in the second quarter of 2025 was $90 million compared to $127 million in the second quarter of 2024, a decrease of $37 million, or 29%. Lower net selling prices (net of cost inflation) decreased segment operating profit by $24 million in the second quarter of 2025 compared to the same period in the prior year due to elevated competitive pressures. The impact of lower shipments discussed above decreased segment operating profit by approximately $18 million. Operating costs in the second quarter of 2025 were $4 million higher than in the same period in the prior year, primarily driven by approximately $38 million from the impact of temporary production curtailments to balance supply and demand and reduce inventory levels. Partially offsetting these higher costs in the second quarter of 2025 were approximately $34 million of benefits from the Fit to Win initiative (exceeding management’s expectations). The effects of foreign currency exchange rates increased segment operating profit by $9 million in the second quarter of 2025.

In addition, the ongoing conflict between Russia and Ukraine has caused a significant change in the global gas market, resulting in a shift toward liquified natural gas.  This transition has increased volatility in the market, as countries have diversified their energy sources and reduced dependance on Russian natural gas supplies. The Company’s European operations typically purchase natural gas under mid- to long-term supply arrangements with terms that range from one to three years and, through these agreements, typically agree on a portion of the price with the relevant supplier in advance of the period in which the natural gas will be delivered, which shields the Company from the full impact of increased natural gas prices, while such agreements remain in effect. The Company’s energy risk management approach is to have coverage of at least 40% of its expected total energy use for the year ahead, where possible. However, the Company’s coverage for its expected European natural gas requirements in 2026 is currently below this level as of June 30, 2025. The Company intends to reach this level by the end of 2025. The current conflict between Russia and Ukraine and the resulting sanctions, potential sanctions, government mandated curtailments or government imposed allocations, tariffs or other adverse repercussions on energy supplies could cause the Company’s energy suppliers to be unable or unwilling to deliver natural gas at agreed prices and quantities. If this occurs, it may be necessary for the Company to procure natural gas at then-current market prices and subject to market availability and could cause the Company to experience a significant increase in operating costs or result in the temporary or permanent cessation of delivery of natural gas to several of the Company’s manufacturing plants in Europe. Depending on the duration and ultimate outcome of the conflict between Russia and Ukraine, future long-term supply arrangements for natural gas may not be available at reasonable prices or at all.

Interest Expense, Net

Net interest expense in the second quarter of 2025 was $85 million compared to $87 million in the second quarter of 2024, primarily due to lower note repurchase premiums, write-offs of deferred finance fees and related charges.

Provision for Income Taxes

The Company’s effective tax rate from operations for the second quarter of 2025 was 85.7% compared to 40.4% for the second quarter of 2024.  The effective tax rate for the second quarter of 2025 differed from the second quarter of 2024 due to a net unfavorable tax rate on restructuring and asset impairment charges, a benefit from a European investment tax incentive and a change in the mix of geographic earnings.

31

Net Earnings (Loss) Attributable to the Company

For the second quarter of 2025, the Company recorded a net loss attributable to the Company of $5 million, or $0.03 per share, compared to net earnings attributable to the Company of $57 million, or $0.36 per share (diluted), in the second quarter of 2024. Net loss and net earnings attributable to the Company in the second quarter of 2025 and 2024 included items that management considers not representative of ongoing operations and other adjustments as set forth in the following table (dollars in millions).

Net Earnings

Increase

(Decrease)

Description

    

2025

2024

Restructuring, asset impairment and other charges

$

(108)

$

Legacy environmental charge

(10)

Charges for note repurchase premiums and write-off of deferred finance fees and related charges

(2)

European investment tax incentive

22

Total

$

(86)

$

(12)

Executive Overview — Six months ended June 30, 2025 and 2024

Net sales for the first six months of 2025 decreased $49 million, or 2%, compared to the same period in the prior year, primarily due to the impact from unfavorable foreign currency translation and lower average selling prices, partially offset by slightly higher sales volumes and favorable mix.

Earnings before income taxes were $195 million lower in the first six months of 2025 compared to the same period in 2024. This decrease was primarily due to higher restructuring, asset impairment and other charges, lower segment operating profit and slightly higher interest expense, partially offset by lower retained corporate and other costs.

Segment operating profit for reportable segments in the first half of 2025 was $34 million lower compared to the prior year period, primarily due to lower net prices (net of cost inflation), partially offset by the impact of slightly higher sales volumes and favorable mix and lower operating costs. Operating costs were favorably impacted by benefits from the Company’s Fit to Win initiative, partially offset by temporary curtailments of production volumes, primarily in Europe, to balance supply and demand and reduce inventory levels.

Net interest expense for the first six months of 2025 increased $1 million compared to the same period in 2024, primarily due to the unfavorable effect of foreign currency exchange rates, partially offset by $2 million in lower note repurchase premiums, write-offs of deferred finance fees and related charges.

For the first six months of 2025, the Company recorded a net loss attributable to the Company of $20 million, or $0.13 per share, compared to net earnings attributable to the Company of $129 million, or $0.81 per share (diluted), for the first six months of 2024. As discussed below, net loss or earnings attributable to the Company in the first six months of 2025 and 2024 included items that management considers not representative of ongoing operations and other adjustments. These items increased net loss attributable to the Company by $165 million, or $1.06 per share, in the first six months of 2025 and decreased net earnings attributable to the Company by $12 million, or $0.08 per share, in the first six months of 2024.

Results of Operations — First Six Months of 2025 Compared with First Six Months of 2024

Net Sales

The Company’s net sales in the first half of 2025 were $3,273 million compared with $3,322 million in the first half of 2024, a decrease of $49 million, or 2%. Average selling prices declined, which decreased net sales by $35 million for the first six months of 2025. Glass container shipments, in tons, were up nearly 1% and mix was more favorable for the first six months of 2025, which increased net sales by approximately $40 million compared to the same period in the

32

prior year. Unfavorable foreign currency exchange rates decreased net sales by $46 million in the first half of 2025 compared to the same period in the prior year. Other sales were approximately $8 million lower for the first six months of 2025 than in the same period in the prior year, driven by lower machine part sales.

The change in net sales of reportable segments can be summarized as follows (dollars in millions):

Reportable segment net sales - 2024

    

    

$

3,264

Price

$

(35)

Sales volume and mix

 

40

Effects of changing foreign currency rates

(46)

Total effect on reportable segment net sales

(41)

Reportable segment net sales - 2025

$

3,223

Americas: Net sales in the Americas in the first six months of 2025 were $1,816 million compared to $1,753 million in the first six months of 2024, an increase of $63 million, or 4%. Higher selling prices in the region increased net sales by $52 million in the first half of 2025, driven by the pass through of higher cost inflation. Glass container shipments in the region were up more than 4% in the first six months of 2025 compared to the same period in the prior year, which increased net sales by approximately $98 million. The segment experienced higher shipments to beer, food and spirits customers. The unfavorable effects of foreign currency exchange rate changes decreased net sales by $87 million in the first half of 2025 compared to the same period in the prior year, as the Brazilian Real, Mexican Peso and Colombian Peso weakened compared to the U.S. dollar.

Europe: Net sales in Europe in the first six months of 2025 were $1,407 million compared to $1,511 million in the first six months of 2024, a decrease of $104 million, or 7%. Lower average selling prices in Europe decreased net sales by $87 million in the first half of 2025. Glass container shipments decreased by approximately 3% in the first six months of 2025 with lower shipments to beer, wine and spirits customers in the first half of 2025, and this decreased net sales by approximately $58 million compared to the same period in the prior year. The Company believes that sales in the first six months of 2025 were adversely impacted by the following factors: a supplier-related delay at a major plant reconfiguration project which is now ramping up, macroeconomic uncertainty and unfavorable weather conditions. Favorable effects of foreign currency exchange rate changes increased net sales by $41 million in the first half of 2025 compared to the same period in the prior year, as the Euro strengthened compared to the U.S. dollar.

Earnings before Income Taxes and Segment Operating Profit

Earnings before income taxes were $26 million in the first six months of 2025 compared to $221 million in the first six months of 2024, a decrease of $195 million.  This decrease was due to higher restructuring, asset impairment and other charges, lower segment operating profit, partially offset by lower retained corporate and other costs.

Segment operating profit of the reportable segments includes an allocation of some corporate expenses based on a percentage of sales and direct billings based on the costs of specific services provided. Unallocated corporate expenses and certain other expenses not directly related to the reportable segments’ operations are included in Retained corporate costs and other. For further information, see Segment Information included in Note 1 to the Condensed Consolidated Financial Statements.

Segment operating profit of reportable segments in the first half of 2025 was $434 million, compared to $468 million in the first half of 2024, a decrease of $34 million, or 7%. This decrease was primarily due to lower net prices (net of cost inflation), partially offset by the impact of slightly higher sales volumes and favorable mix and lower operating costs. Operating costs were favorably impacted by approximately $110 million of benefits from the Company’s Fit to Win initiative and $7 million from the settlement of an insurance claim in the Americas, partially offset by approximately $86 million related to temporary curtailments of production volumes, primarily in Europe, to balance supply and demand and reduce inventory levels. Unfavorable foreign currency exchange rates decreased segment operating profit by $4 million in the first half of 2025 compared to the same period in the prior year.

33

The change in segment operating profit of reportable segments can be summarized as follows (dollars in millions):

Reportable segment operating profit - 2024

    

    

    

$

468

Net price (net of cost inflation)

$

(70)

Sales volume and mix

9

Operating costs

 

31

Effects of changing foreign currency rates

(4)

Total net effect on reportable segment operating profit

(34)

Reportable segment operating profit - 2025

$

434

Americas: Segment operating profit in the Americas in the first six months of 2025 was $276 million, compared to $208 million in the first six months of 2024, an increase of $68 million, or 33%. The impact of higher shipments discussed above resulted in a $21 million increase to segment operating profit in the first six months of 2025 compared to the same period in the prior year. Higher cost inflation exceeded higher selling prices and resulted in a $8 million decrease to segment operating profit in the first half of 2025. The effects of foreign currency exchange rates decreased segment operating profit by $11 million in the first half of 2025.

In addition, operating costs in the first half of 2025 were $66 million lower than in the same period in the prior year, primarily due to approximately $56 million in savings from the Company’s Fit To Win initiative (exceeding management’s expectations). Operating costs were also favorably impacted by approximately $7 million from the settlement of an insurance claim.

In late July 2025, the Company finalized its plans for the indefinite suspension of operations of one furnace and the closure of one plant in its Americas segment. The Company will continue to monitor business trends and consider whether any additional temporary downtime or permanent capacity closures in the Americas will be necessary in 2025 to align its business with demand trends.  Any permanent capacity closures could result in material restructuring and impairment charges, as well as cash expenditures, in future periods.

Europe: Segment operating profit in Europe in the first six months of 2025 was $158 million compared to $260 million in the first six months of 2024, a decrease of $102 million, or 39%. Lower net selling prices (net of cost inflation) decreased segment operating profit by $62 million in the first half of 2025 compared to the same period in the prior year due to elevated competitive pressures. Operating costs in the first six months of 2025 were $35 million higher than in the same period in the prior year, driven by approximately $89 million from the impact of temporary production curtailments to balance supply and demand and reduce inventory levels and other costs. Partially offsetting these higher costs in the first half of 2025 were approximately $54 million of benefits from the Fit to Win initiative (exceeding management’s expectations). The impact of lower shipments discussed above decreased segment operating profit by approximately $12 million. The effects of foreign currency exchange rates increased segment operating profit by $7 million in the first half of 2025.

In the first six months of 2025, the Company also announced the permanent closure of a plant and the elimination of a number of selling, general and administrative positions in Europe in connection with its Fit to Win initiative. Additional indefinite or permanent capacity closures and job eliminations in Europe may be necessary in 2025 to align its business with demand trends.  Any indefinite or permanent capacity closures could result in material restructuring and impairment charges, as well as cash expenditures, in future periods.

In addition, the ongoing conflict between Russia and Ukraine has caused a significant change in the global gas market, resulting in a shift toward liquified natural gas.  This transition has increased volatility in the market, as countries have diversified their energy sources and reduced dependance on Russian natural gas supplies. The Company’s European operations typically purchase natural gas under mid- to long-term supply arrangements with terms that range from one to three years and, through these agreements, typically agree on a portion of the price with the relevant supplier in advance of the period in which the natural gas will be delivered, which shields the Company from the full impact of increased natural gas prices, while such agreements remain in effect. The Company’s energy risk management approach is to have coverage of at least 40% of its expected total energy use for the year ahead, where possible. However, the Company’s coverage for its expected European natural gas requirements in 2026 is currently

34

below this level as of June 30, 2025. The Company intends to reach this level by the end of 2025. The current conflict between Russia and Ukraine and the resulting sanctions, potential sanctions, government mandated curtailments or government imposed allocations, tariffs or other adverse repercussions on energy supplies could cause the Company’s energy suppliers to be unable or unwilling to deliver natural gas at agreed prices and quantities. If this occurs, it may be necessary for the Company to procure natural gas at then-current market prices and subject to market availability and could cause the Company to experience a significant increase in operating costs or result in the temporary or permanent cessation of delivery of natural gas to several of the Company’s manufacturing plants in Europe. Depending on the duration and ultimate outcome of the conflict between Russia and Ukraine, future long-term supply arrangements for natural gas may not be available at reasonable prices or at all.

Interest Expense, Net

Net interest expense in the first six months of 2025 was $166 million compared to $165 million in the first six months of 2024. This increase was primarily due to the unfavorable effect of foreign currency exchange rates, partially offset by $2 million in lower note repurchase premiums, write-offs of deferred finance fees and related charges.

Provision for Income Taxes

The Company’s effective tax rate from operations for the six months ended June 30, 2025 was 138.5% compared to 37.6% for the six months ended June 30, 2024.  The effective tax rate for the first half of 2025 differed from the first half of 2024 due to a net unfavorable tax rate on restructuring charges, a benefit from a European investment tax incentive and a change in the mix of geographic earnings.

Net Earnings (Loss) Attributable to the Company

For the first six months of 2025, the Company recorded a net loss attributable to the Company of $20 million, or $0.13 per share, compared to net earnings attributable to the Company of $129 million, or $0.81 per share (diluted), in the first six months of 2024. Net loss and net earnings attributable to the Company in the first six months of 2025 and 2024 included items that management considers not representative of ongoing operations and other adjustments as set forth in the following table (dollars in millions).

Net Earnings

Increase

(Decrease)

Description

    

2025

2024

Restructuring, asset impairment and other charges

$

(191)

$

Legacy environmental charge

(4)

(10)

Gain on sale of miscellaneous assets

6

Charges for note repurchase premiums and write-off of deferred finance fees and related charges

(2)

European investment tax incentive

22

Net benefit for income tax on items above

2

Total

$

(165)

$

(12)

35

Research, Development and Engineering

In the second quarter of 2025, the Company revised its approach regarding the use of research, development and engineering activities from those reported in its 2024 Form 10-K. Following a comprehensive evaluation, the Company has decided to halt further MAGMA development and operations. The Company concluded that the MAGMA program had not met the operational and financial thresholds required. As a result of the decision to halt the MAGMA program, the Company has recorded approximately $104 million of restructuring, asset impairment and other charges in the second quarter of 2025.

In addition, future spending on research, development and engineering activities is expected to significantly decline given the decision to halt further MAGMA development and operations. The Company intends to continue with its plans to roll out ULTRA, its proprietary technology which seeks to reduce the weight of its glass containers by up to 30%, and expects to work closely with select third-party vendors in a strategic way to assist with future research, development and engineering needs for those projects in which additional resources or expertise are needed.

Forward-Looking Operational and Financial Information

The Company is maintaining its cautious commercial outlook and guidance for stable sales volumes in 2025 compared to 2024 levels given uncertainty around tariffs which could affect future demand. For the month of July 2025, the Company’s global shipments were down by a mid-single digit percentage compared to the month of July 2024, reflecting continued soft conditions and the rephasing of some specific customer order activity and the delayed ramp up of the Company’s plant reconfiguration project in Europe. Year-to-date through July 2025, shipments were flat compared to the same period in the prior year and reflected softer demand recently amid uncertainty of new tariff policies.
Net price (net of cost inflation) is expected to be a headwind again in 2025 due to competitive pressures in Europe.
Management anticipates generating at least $250 million of Fit To Win benefits in 2025. On a cumulative basis, the Company expects at least $650 million of Fit To Win benefits through 2027 (with 2024 as a baseline).
Cash provided by operating activities is expected to approximate $600 million for 2025. Capital expenditures in 2025 are expected to range between approximately $400 million and $450 million.

Items Excluded from Reportable Segment Totals

Retained Corporate Costs and Other

Retained corporate costs and other for the second quarter of 2025 were $25 million compared to $32 million in the second quarter of 2024 and were $53 million in the first six months of 2025 compared to $72 million for the same period in 2024. These costs decreased in the second quarter and first six months of 2025, driven by approximately $21 million and $35 million, respectively, of benefits from the Company’s Fit To Win initiative (exceeding management’s expectations), partially offset by other costs including higher management incentives.

The Company has initiated a strategic review of the remaining businesses in the former Asia Pacific region. This review is aimed at exploring options to maximize share owner value, focused on aligning the Company’s business with demand trends and improving the Company’s operating efficiency, cost structure and working capital management. The review is ongoing and may result in divestitures, corporate transactions or similar actions, and could cause the Company to incur restructuring, impairment, disposal or other related charges in future periods.

36

Restructuring, Asset Impairment and Other Charges

For the three and six months ended June 30, 2025, the Company recorded restructuring, asset impairment and other charges of approximately $108 million (which included $104 million related to its decision to halt the MAGMA program) and $191 million, respectively, to Other expense, net in the Condensed Consolidated Results of Operations, primarily related to the Fit to Win program. For the three months ended June 30, 2025, these charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($45 million), Europe segment ($3 million) and Retained corporate costs and other ($60 million). For the six months ended June 30, 2025, these charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($52 million), Europe segment ($55 million) and Retained corporate costs and other ($84 million). As of June 30, 2025, the Company has incurred cumulative charges of approximately $396 million related to the Fit to Win program. Additional restructuring charges are expected in future quarters when management completes their assessment to reduce redundant production capacity and streamline costs.

The Company expects that the majority of the remaining cash expenditures related to the accrued employee and other exit costs will be paid out over the next several years.

Legacy Environmental Charge

From December 31, 1956 through June 1967, the Company, via a wholly-owned subsidiary, owned and operated a paper mill located on the shore of the Cuyahoga River in Ohio, which is now part of the Cuyahoga Valley National Park that is managed by the National Park Service (“NPS”).  The Company and the United States have been engaged in litigation regarding the site in the U.S. District Court for the Northern District of Ohio (Akron), with the United States claiming that the Company should pay $50 million as a remedy for certain soils at the site as well as its past and anticipated future costs. In the first quarter of 2025, the Company and the NPS reached a tentative settlement, and the Company expects to pay $16.5 million in the third quarter of 2025 to resolve this matter. As a result, the Company recorded a charge of approximately $4 million in the first quarter of 2025 to Other expense, net in the Condensed Consolidated Results of Operations to augment its previous approximate $12.5 million accrual balance related to this matter.  The Company recorded a charge of $10 million in the second quarter of 2024 related to this matter.

Gain on Sale of Miscellaneous Assets

In the first quarter of 2025, the Company recorded a pre-tax gain of approximately $6 million on the sale of land and buildings of a previously closed plant in the Americas.

Capital Resources and Liquidity

On March 25, 2022, certain of the Company’s subsidiaries entered into a Credit Agreement and Syndicated Facility Agreement (the “Original Agreement”), which refinanced in full the previous credit agreement. The Original Agreement provided for up to $2.8 billion of borrowings pursuant to term loans, revolving credit facilities and a delayed draw term loan facility. The delayed draw term loan facility allowed for a one-time borrowing of up to $600 million, the proceeds of which were used, in addition to other consideration paid by the Company and/or its subsidiaries, to fund an asbestos settlement trust (the “Paddock Trust”) established in connection with the confirmed plan of reorganization of Paddock Enterprises, LLC (“Paddock”) proposed by Paddock, O-I Glass and certain other parties in Paddock’s Chapter 11 case. On July 18, 2022, the Company drew down the $600 million delayed draw term loan to fund, together with other consideration, the Paddock Trust.

On August 30, 2022, certain of the Company’s subsidiaries entered into an Amendment No. 1 to its Credit Agreement and Syndicated Facility Agreement (the “Credit Agreement Amendment”), which amends the Original Agreement (as amended by the Credit Agreement Amendment, the “Credit Agreement”). The Credit Agreement Amendment provides for up to $500 million of additional borrowings in the form of term loans. The proceeds of such term loans were used, together with cash, to retire the $600 million delayed draw term loan. The term loans mature, and the revolving credit facilities terminate, in March 2027. The term loans borrowed under the Credit Agreement Amendment are secured by certain collateral of the Company and certain of its subsidiaries. In addition, the Credit

37

Agreement Amendment makes modifications to certain loan documents, in order to give the Company increased flexibility to incur secured debt in the future.

At June 30, 2025, the Credit Agreement includes a $300 million revolving credit facility, a $950 million multicurrency revolving credit facility and $1.45 billion in term loan A facilities ($1.34 billion outstanding balance at June 30, 2025, net of debt issuance costs). At June 30, 2025, the Company had unused credit of $1.04 billion available under the revolving credit facilities as part of the Credit Agreement. The weighted average interest rate on borrowings outstanding under the Credit Agreement at June 30, 2025 was 6.08%.

The Credit Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain indebtedness and liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations.

The Credit Agreement also contains one financial maintenance covenant, a Secured Leverage Ratio (as defined in the Credit Agreement), that requires the Company not to exceed a ratio of 2.50x calculated by dividing consolidated Net Indebtedness that is then secured by Liens on property or assets of the Company and certain of its subsidiaries by Consolidated EBITDA, as each term is defined and as described in the Credit Agreement. The Secured Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Secured Leverage Ratio to exceed the specified maximum.

Failure to comply with these covenants and restrictions could result in an event of default under the Credit Agreement. In such an event, the Company could not request additional borrowings under the revolving facilities, and all amounts outstanding under the Credit Agreement, together with accrued interest, could then be declared immediately due and payable. Upon the occurrence and for the duration of a payment event of default, an additional default interest rate equal to 2.0% per annum will apply to all overdue obligations under the Credit Agreement. If an event of default occurs under the Credit Agreement and the lenders cause all of the outstanding debt obligations under the Credit Agreement to become due and payable, this would result in a default under the indentures governing the Company’s outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of June 30, 2025, the Company was in compliance with all covenants and restrictions in the Credit Agreement.  In addition, the Company believes that it will remain in compliance for the term of the Credit Agreement and that its ability to borrow additional funds under the Credit Agreement will not be adversely affected by the covenants and restrictions.

The Total Leverage Ratio (as defined in the Credit Agreement) determines pricing under the Credit Agreement. The interest rate on borrowings under the Credit Agreement is, at the Company’s option, the Base Rate, Term SOFR or, for non-U.S. dollar borrowings only, the Eurocurrency Rate (each as defined in the Credit Agreement), plus an applicable margin. The applicable margin is linked to the Total Leverage Ratio. The margins range from 1.00% to 2.25% for Term SOFR loans and Eurocurrency Rate loans and from 0.00% to 1.25% for Base Rate loans. In addition, a commitment fee is payable on the unused revolving credit facility commitments ranging from 0.20% to 0.35% per annum linked to the Total Leverage Ratio.

Obligations under the Credit Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Such obligations are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign obligations, of stock of certain foreign subsidiaries. All obligations under the Credit Agreement are guaranteed by certain domestic subsidiaries of the Company, and certain foreign obligations under the Credit Agreement are guaranteed by certain foreign subsidiaries of the Company.

In May 2024, the Company issued €500 million aggregate principal amount of senior notes that bear interest at 5.250% and mature on June 1, 2029. Also, in May 2024, the Company issued $300 million aggregate principal amount of senior notes that bear interest at 7.375% and mature on June 1, 2032. The senior notes were issued via private placements and are guaranteed by certain of the Company’s subsidiaries. The net proceeds, after deducting debt issuance

38

costs, were used to repurchase and redeem the aggregate principal amounts described in the May 2024 tender offer and redemption below.

In May 2024, the Company repurchased 323.4 million aggregate principal amount of the outstanding 2.875% Senior Notes due 2025 pursuant to a tender offer and redeemed $300 million aggregate principal amount of the outstanding 6.375% Senior Notes due 2025. The repurchase and redemption were funded with the proceeds from the May 2024 senior notes issuances described above. The Company recorded approximately $2 million of additional interest charges related to the senior note repurchases conducted in the second quarter of 2024 for note repurchase premiums and the write-off of unamortized finance fees. In the first quarter of 2025, the 2.875% Senior Notes due 2025 were fully repaid.  

The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market.

Material Cash Requirements

There have been no material changes to the Company’s material cash requirements at June 30, 2025 from those described in Part II, Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations - Capital Resources and Liquidity - Material Cash Requirements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Cash Flows

Operating activities: Cash utilized in operating activities was $16 million and $20 million for the six months ended June 30, 2025 and 2024, respectively. The decrease in cash utilized in operating activities in the first six months of 2025 was primarily due to a lower use of working capital, partially offset by lower net income and higher cash paid for restructuring activities than in the same period in 2024.

Working capital was a use of cash of $335 million in the first six months of 2025, compared to a use of cash of $439 million in the same period in 2024. The reduction in working capital as a use of cash for the six months ended June 30, 2025 reflects lower inventory levels compared to the same period in the prior year. The Company’s use of its accounts receivable factoring programs resulted in a increase to cash provided by operating activities of approximately $9 million and $90 million for the six months ended June 30, 2025 and 2024, respectively. Excluding the impact of accounts receivable factoring, the Company’s days sales outstanding as of June 30, 2025 were comparable to June 30, 2024.

Investing activities: Cash utilized in investing activities was $221 million and $380 million for the six months ended June 30, 2025 and 2024, respectively. Capital spending for property, plant and equipment was $239 million during the first six months of 2025, compared to $373 million in the same period in 2024, reflecting lower spending as the Company was constructing a new plant in Bowling Green, Kentucky and several other expansion projects in 2024 that did not reoccur in the first half of 2025. The Company estimates that its full year 2025 capital expenditures is expected to range between approximately $400 million and $450 million. Net cash proceeds on the sale of miscellaneous assets was $18 million and $6 million, for the six months ended June 30, 2025 and 2024, respectively, reflecting higher proceeds on the sale of land and buildings of a previously closed plant in the Americas.

Financing activities: Cash utilized in financing activities was $47 million and cash provided by financing activities was $180 million for the six months ended June 30, 2025 and 2024, respectively. Financing activities included additions to long-term debt of $680 million and $1,096 million for the six-month periods ended June 30, 2025 and 2024, respectively. Financing activities included repayments of long-term debt of $698 million and $917 million for the six-month periods ended June 30, 2025 and 2024, respectively. Short-term loans increased by $12 million and $54 million for the six months ended June 30, 2025 and 2024, respectively. During each of the six-month periods ended June 30, 2025 and 2024, the Company repurchased $20 million of its common stock.

39

The Company anticipates that cash flows from its opera­tions and from utiliza­tion of credit available under the revolving credit facilities provided by the Credit Agreement will be sufficient to fund its operating and seasonal working capital needs, debt service and other obligations on a short-term (the next 12 months) and long-term basis (beyond the next 12 months). However, as the Company cannot predict the impact from tariffs and other changes in global trade policies and the outcome of the conflict between Russia and Ukraine and its impact on the Company’s customers and suppliers, the negative financial impact to the Company’s results cannot be reasonably estimated but could be material. The Company is actively managing its business to maintain cash flow, and it has significant liquidity. The Company believes that these factors will allow it to meet its anticipated funding requirements.

Critical Accounting Estimates

The Company’s analysis and discussion of its financial condition and results of operations are based upon its Condensed Consolidated Financial Statements that have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. The Company evaluates these estimates and assumptions on an ongoing basis. Estimates and assumptions are based on historical and other factors believed to be reasonable under the circumstances at the time the financial statements are issued. The results of these estimates may form the basis of the carrying value of certain assets and liabilities and may not be readily apparent from other sources. Actual results, under conditions and circumstances different from those assumed, may differ from estimates.

The impact of, and any associated risks related to, estimates and assumptions are discussed within Management’s Discussion and Analysis of Financial Condition and Results of Operations, as well as in the Notes to the Condensed Consolidated Financial Statements, if applicable, where estimates and assumptions affect the Company’s reported and expected financial results.

There have been no other material changes in critical accounting estimates at June 30, 2025 from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Forward-Looking Statements

This document contains “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Section 27A of the Securities Act of 1933, as amended. Forward-looking statements reflect the company’s current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words “believe,” “expect,” “anticipate,” “will,” “could,” “would,” “should,” “may,” “plan,” “estimate,” “intend,” “predict,” “potential,” “continue,” “target,” “commit,” and the negatives of these words and other similar expressions generally identify forward-looking statements.

It is possible that the Company’s future financial performance may differ from expectations due to a variety of factors including, but not limited to the following: (1) the Company’s ability to achieve expected benefits from cost management, efficiency improvements, and profitability initiatives, such as its Fit to Win program, including expected impacts from production curtailments, reduction in force and furnace closures, (2) the general political, economic, legal and competitive conditions in markets and countries where the Company has operations, including uncertainties related to economic and social conditions, trade policies and disputes, financial market conditions, disruptions in the supply chain, competitive pricing pressures, inflation or deflation, changes in tax rates, changes in laws or policies, legal proceedings involving the Company, war, civil disturbance or acts of terrorism, natural disasters, public health issues and weather, (3) cost and availability of raw materials, labor, energy and transportation (including impacts related to the current Ukraine-Russia and Israel-Hamas conflicts and disruptions in supply of raw materials caused by transportation delays), (4) competitive pressures from other glass container producers and alternative forms of packaging or consolidation among competitors and customers, (5) changes in consumer preferences or customer inventory management practices, (6) the continuing consolidation of the Company’s customer base, (7) impacts from the Company’s decision to halt further MAGMA development and operations, (8) unanticipated supply chain and operational disruptions, including higher capital spending, (9) seasonality of customer demand, (10) the failure of the

40

Company’s joint venture partners to meet their obligations or commit additional capital to the joint venture, (11) labor shortages, labor cost increases or strikes, (12) the Company’s ability to acquire or divest businesses, acquire and expand plants, integrate operations of acquired businesses and achieve expected benefits from acquisitions, divestitures or expansions, (13) the Company’s ability to generate sufficient future cash flows to ensure the Company’s goodwill is not impaired, (14) any increases in the underfunded status of the Company’s pension plans, (15) any failure or disruption of the Company’s information technology, or those of third parties on which the Company relies, or any cybersecurity or data privacy incidents affecting the company or its third-party service providers, (16) risks related to the Company’s indebtedness or changes in capital availability or cost, including interest rate fluctuations and the ability of the Company to generate cash to service indebtedness and refinance debt on favorable terms, (17) risks associated with operating in foreign countries, (18) foreign currency fluctuations relative to the U.S. dollar, (19) changes in tax laws or global trade policies, (20) the Company’s ability to comply with various environmental legal requirements, (21) risks related to recycling and recycled content laws and regulations, (22) risks related to climate-change and air emissions, including related laws or regulations and increased ESG scrutiny and changing expectations from stakeholders, and the other risk factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and any subsequently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q or the Company’s other filings with the Securities and Exchange Commission.

It is not possible to foresee or identify all such factors. Any forward-looking statements in this document are based on certain assumptions and analyses made by the Company in light of its experience and perception of historical trends, current conditions, expected future developments, and other factors it believes are appropriate in the circumstances. Forward-looking statements are not a guarantee of future performance, and actual results or developments may differ materially from expectations. While the Company continually reviews trends and uncertainties affecting the Company’s results of operations and financial condition, the Company does not assume any obligation to update or supplement any particular forward-looking statements contained in this document.

41

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no material changes in market risk at June 30, 2025 from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Item 4. Controls and Procedures.

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Also, the Company has investments in certain unconsolidated entities. As the Company does not control or manage these entities, its disclosure controls and procedures with respect to such entities are necessarily substantially more limited than those maintained with respect to its consolidated subsidiaries.

As required by Rule 13a-15(b) of the Exchange Act, the Company carried out an evaluation, under the supervision and with the participation of management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2025.

As required by Rule 13a-15(d) of the Exchange Act, the Company carried out an evaluation, under the supervision and with the participation of management, including its Chief Executive Officer and Chief Financial Officer, of any change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

42

PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

SEC regulations require the Company to disclose certain information about environmental proceedings if the Company reasonably believes that such proceedings may result in monetary sanctions above a stated threshold. The Company uses a threshold of $1 million for purposes of determining whether disclosure of any such proceedings is required.  Except as disclosed in Note 10 to the Condensed Consolidated Financial Statements, no such proceedings were pending or contemplated as of June 30, 2025.

For further information on legal proceedings, see Note 10 to the Condensed Consolidated Financial Statements, which is included in Part I of this Quarterly Report and incorporated herein by reference.

Item 1A. Risk Factors.

Except as set forth below, there have been no material changes in risk factors at June 30, 2025 from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Global Economic and Legal Environment—The global credit, financial, economic and legal environment could have a material adverse effect on operations and financial condition.

The global credit, financial, economic and legal environment can be negatively impacted by numerous events or occurrences, including political events, trade policies and disputes, acts of terrorism, hostilities or wars, natural disasters and public health issues, such as a pandemic. For example, the current conflicts between Russia and Ukraine and Hamas and Israel, as well as any further escalation or expansion of these conflicts, and any related economic sanctions or other impacts could adversely impact the global credit, financial, economic and legal environment, which could have a material adverse effect on the Company’s operations, including the following:

Downturns in the business or financial condition of any of the Company’s customers or suppliers could result in a loss of revenues or a disruption in the supply of raw materials;
Unfavorable macroeconomic conditions, such as a recession or continued slowed economic growth and uncertainty surrounding international trade policies and regulations as well as disputes and protectionist measures, could negatively affect consumer demand for the Company’s products;
Cost inflation, including as a result of imposition of or increase in tariffs, could negatively impact the Company’s costs for energy, labor, materials and services, and impact the Company’s profitability if increased costs are not fully passed on to customers through increased prices of the Company’s products;
Changes in laws or policies governing the terms of foreign trade, and in particular increased trade restrictions, tariffs or taxes on imports or exports from or to countries where the Company manufactures or sells, or its customers sells, its products may affect the prices of and demand for the Company’s products;
Tightening of credit in financial markets or increasing interest rates could reduce the Company’s ability, as well as the ability of the Company’s customers and suppliers, to obtain future financing;
Volatile market performance could affect the fair value of the Company’s pension assets and liabilities, potentially requiring the Company to make significant additional contributions to its pension plans to maintain prescribed funding levels, and may lead to adverse changes in the availability, terms and cost of capital;
The deterioration of any of the lending parties under the Company’s revolving credit facility or the creditworthiness of the counterparties to the Company’s derivative transactions could result in such parties’ failure to satisfy their obligations under their arrangements with the Company;

43

A significant weakening of the Company’s financial position or results of operations could result in noncompliance with the covenants under the Company’s indebtedness; and
Legal proceedings arising from the Company’s business, including governmental investigations and other government actions could be costly, time-consuming and disruptive to the Company’s operations.

Global Profitability Improvement Initiatives—The Company’s ability to achieve expected benefits from cost management, efficiency improvements, and profitability initiatives, such as its Fit to Win program, including expected impacts from production curtailments, reductions in force and furnace closures, could have a material adverse effect on operations and financial condition.

Beginning in 2024, the Company commenced a strategic review of its global profitability and manufacturing footprint, known as its Fit to Win initiative. This initiative is focused on the reduction of redundant production capacity and the optimization of its network, as well as streamlining other costs, such as selling, general and administrative expenses.  In connection with the Fit to Win initiative, in the second quarter of 2025, the Company decided to halt further MAGMA development and operations. With the halt of the MAGMA program, the Company’s Fit to Win initiative is now intended to be the primary program to drive higher output at lower operating costs. The Fit to Win initiative is currently expected to last at least through 2026.

Since 2024, this program has resulted in significant cumulative pre-tax charges and cash outflows for severance and other exit costs, and future actions under this program, or similar profitability initiatives, may result in additional costs. If the Company fails to complete any of these initiatives or activities, or if the results of these initiatives and activities do not lead to the expected cost savings, the Company’s financial results could be negatively impacted.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the three months ended June 30, 2025, the Company purchased 938,029 shares of its common stock for approximately $10 million. The share purchases were made pursuant to a $100 million anti-dilutive share repurchase program authorized by the Company’s Board of Directors on May 14, 2024, which is intended to offset stock-based compensation provided to the Company’s directors, officers, and employees. Approximately $60 million remained available for purchases under this program as of June 30, 2025. The share repurchase program has no expiration date. The following table provides information about the Company’s purchases of its common stock during the three months ended June 30, 2025:

Issuer Purchases of Equity Securities

Period

    

Total Number of Shares Purchased (in thousands)

    

Average Price Paid per Share

    

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs

    

Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions)

    

April 1 - April 30, 2025

938

10.64

938

60

May 1 - May 31, 2025

60

June 1 - June 30, 2025

60

Total

938

10.64

938

44

Item 5. Other Information.

During the three months ended June 30, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

Item 6. Exhibits.

Exhibit 10.1*

O-I Glass, Inc. Fifth Amended and Restated 2017 Incentive Award Plan (filed as Appendix B to O-I Glass, Inc.’s Definitive Proxy Statement on Schedule 14A filed April 1, 2025, File No. 1-9576, and incorporated herein by reference)

Exhibit 10.2*

Form of Director Restricted Stock Unit Agreement for use under the O-I Glass, Inc. Fifth Amended and Restated 2017 Incentive Award Plan.

Exhibit 10.3*

Form of Employee Performance Stock Unit Agreement for use under the O-I Glass, Inc. Fifth Amended and Restated 2017 Incentive Award Plan.

Exhibit 10.4*

Form of Employee Restricted Stock Unit Agreement for use under the O-I Glass, Inc. Fifth Amended and Restated 2017 Incentive Award Plan.

Exhibit 31.1

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.2

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 32.1**

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350.

Exhibit 32.2**

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350.

Exhibit 101

Financial statements from the Quarterly Report on Form 10-Q of O-I Glass, Inc. for the quarterly period ended June 30, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Results of Operations, (ii) the Condensed Consolidated Comprehensive Income (Loss), (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Cash Flows and (v) the Notes to Condensed Consolidated Financial Statements.

Exhibit 104

Cover Page Interactive Data file (formatted as iXBRL and contained in Exhibit 101).

*

Indicates a management contract or compensatory plan or arrangement required to be filed as an exhibit to this report.

**

This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

45

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

O-I GLASS, INC.

Date

July 30, 2025

By

/s/ John A. Haudrich

John A. Haudrich

Senior Vice President and Chief Financial Officer

46

FAQ

How much capital did Celularity (CELU) raise in the July 2025 private placement?

The company raised $2.0 million in gross proceeds from the sale of shares and warrants.

What is the price and structure of the new Celularity units?

Each unit consists of one Class A share plus a warrant, sold at $1.625 per unit.

At what price can the new Celularity warrants be exercised?

The two-year warrants are exercisable immediately at $1.50 per share.

How will Celularity use the proceeds from this financing?

Management states the net proceeds will fund working capital and general corporate purposes.

Will the transaction dilute existing Celularity shareholders?

Yes. The share issuance represents roughly 3-4 % dilution, with further dilution possible if warrants are exercised.
O-I Glass Inc

NYSE:OI

OI Rankings

OI Latest News

OI Latest SEC Filings

OI Stock Data

2.24B
151.72M
2.1%
100.66%
3.66%
Packaging & Containers
Glass Containers
Link
United States
PERRYSBURG